Verified Supplement Data Primary-sourced

FDA Banned Supplements List 2026 + DoD Prohibited List

By Erin Rose · Published · Sources fetched 2026-09-21 · Methodology · Open data (JSON)

Not medical advice. This page reproduces public FDA and Department of Defense lists with their source links; it does not test products and does not say whether any product on Amazon contains these ingredients.

Quick answer

FDA does not publish a single “banned supplements” list. Three lists exist, and they are different things. The FDA Health Fraud Product Database names products found to contain a hidden drug: 1,406 such notifications from 2007 to 2026, 81 of them in the last 12 months. FDA’s Dietary Supplement Ingredient Directory lists 84 ingredients FDA has made a statement about, 61 of which it says cannot lawfully be in a supplement. The DoD prohibited-ingredients list applies to service members: 850 entries reachable through its search (a lower bound), last updated by OPSS on 26 May 2026.

A product can be legal for you and prohibited for a soldier; an ingredient can be on no list and still be undeclared sildenafil in a “natural” capsule. How to check a product →

FDA hidden-ingredient notifications1,4062007–2026, fetched 2026-09-21
FDA: not a lawful ingredient61/84ingredient directory, current as of 2026-05-01
DoD prohibited entries850OPSS list updated 26 May 2026
On this page
  1. FDA: unlawful ingredients
  2. FDA: tainted products
  3. DoD prohibited list
  4. How it reaches a bottle
  5. How to check a product
  6. FAQ

List 1: ingredients FDA says cannot lawfully be in a supplement

SourceFDA, Dietary Supplement Ingredient Directory (“Information on Select Dietary Supplement Ingredients and Other Substances”), content current as of 2026-05-01, fetched 2026-09-21: 84 entries. Each entry carries FDA’s category code; codes 3 to 7 mean FDA has said the substance is not a lawful dietary ingredient, is a drug, or has not met the safety standard. Codes 1 and 2 are health-claim letters and safety communications, not bans, and are listed separately below.

IngredientOther namesFDA status (category)FDA actionListed / updated
1,4 DMAA 1,4-dimethylamylamine; 1,4-dimethylpentylamine 3: not a dietary ingredient (201(ff)(1)) Safety Communication; Hi Tech Pharmaceuticals Voluntary Recall 2023/04
5-Alpha-Hydroxy-Laxogenin 5-laxogenin; 5a-Hydroxy-Laxogenin; (25R)-3beta,5alpha -Dihydroxyspirostan-6-one; 25-R-Spirostan-5A-Diol-6 -One-3-One 3: not a dietary ingredient (201(ff)(1)) Constituent update and warning letters; Advanced Nutritional Supplements LLC Warning Letter 2023/03
7-hydroxymitragynine 7-HMG; 7-hydroxy; 7-OH; 7-OH-MIT 2: safety communication; 6: new dietary ingredient fails the safety standard (402(f)(1)(B)) Hiding in Plain Sight: 7-OH Products; Press release and warning letters 2025/12
Acacia rigidula Vachellia rigidula; Chaparro Prieto; Blackbrush 7: new dietary ingredient with no premarket notification (413(a)(2)) Acacia rigidula in Dietary Supplements; Constituent update and warning letters 2023/03
Acetaminophen Acetamide, N-(4-hydroxyphenyl)-; Paracetamol; Tylenol™ 4: excluded from the supplement definition (201(ff)(3): a drug) Procter and Gamble Warning Letter 2023/04
ALA Phosphate 5-aminolevulinic acid phosphate; NatuALA 4: excluded from the supplement definition (201(ff)(3): a drug) Neo ALA NDIN 1094 Response Letter 2023/06
Amanita muscaria Fly agaric; Fly amanita; ibotenic acid; muscimol 2: safety communication; 6: new dietary ingredient fails the safety standard (402(f)(1)(B)) Constituent Update 2025/12
Aminophylline Aminocardol; Cardiomin; Stenovasan; Vasofilina 4: excluded from the supplement definition (201(ff)(3): a drug) RT Naturals, LLC Warning Letter 2023/04
Anatabine Anatabloc 3: not a dietary ingredient (201(ff)(1)); 4: excluded from the supplement definition (201(ff)(3): a drug) Rock Creek Pharmaceuticals NDIN 840 Response Letter; Star Scientific, Inc. Warning Letter 2023/04
Aspirin Acetylsalicylic acid; 2-Acetoxybenzoic acid; 2-Carboxyphenyl acetate; Kyselina 2-acetoxybenzoova 4: excluded from the supplement definition (201(ff)(3): a drug) Bayer HealthCare L.L.C Warning Letter 2023/04
BMPEA R-beta-methylphenethylamine; R-beta-methylphenethylamine HCl; Beta-methylphenethylamine; 2- phenyl-1-propanamine 3: not a dietary ingredient (201(ff)(1)) BMPEA in Dietary Supplements; Constituent update and warning letters 2023/03
Calcifediol 25-hydroxycholecalciferol; 25-hydroxy vitamin D3; Calcifediol anhydrous; Dedrogyl 4: excluded from the supplement definition (201(ff)(3): a drug) DSM Nutritional Products NDIN 945 Response Letter 2023/04
Cannabidiol CBD 4: excluded from the supplement definition (201(ff)(3): a drug) FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD); Warning Letters and Test Results for Cannabidiol-Related Products 2023/03
Cesium chloride 2: safety communication; 6: new dietary ingredient fails the safety standard (402(f)(1)(B)) Cesium Chloride in Dietary Supplements; Safety communication 2023/03
Chlorzoxazone 2-Hydroxy-5-chlorobenzoxazole; 5-Chlorbenzoxazolin-2-on; 5-Chloro-2-benzoxazolinone; 5-Chloro-2-benzoxazolol 4: excluded from the supplement definition (201(ff)(3): a drug) West Coast Laboratories, Inc. Warning Letter; Human Science Foundation Warning Letter 2023/04
Cotinine HCl Cotinine; 1-methyl-5-(3-pyridinyl)-2 -pyrrolidinone 4: excluded from the supplement definition (201(ff)(3): a drug) Capsulean LLC NDIN 1122 Response Letter 2023/04
Dapoxetine Dapoxetinum 4: excluded from the supplement definition (201(ff)(3): a drug) Shoreside Enterprises, Inc. Warning Letter 2023/04
Diclofenac Dichlofenac; Diclophenac; Feloran; Novapirina 4: excluded from the supplement definition (201(ff)(3): a drug) Naturista Store LLC Warning Letter; Safety Communication 2026/05
DMAA 1,3-DMAA; 1,3-Dimethylamylamine; 1,3-Dimethylpentylamine; 4-Methyl-2-hexanamine 3: not a dietary ingredient (201(ff)(1)) DMAA in Products Marketed as Dietary Supplements 2023/03
DMBA 1,3-Dimethylbutylamine; 4-Amino-2-Methylpentane Citrate; 4-Amino Methylpentane Citrate; Amperall 7: new dietary ingredient with no premarket notification (413(a)(2)) DMBA in Dietary Supplements; Constituent update and warning letters 2023/03
DMHA 1,5-Dimethylhexylamine; 1,5-DMHA; 2-amino-6-methylheptane; 2-aminoisoheptane 3: not a dietary ingredient (201(ff)(1)) DMHA in Dietary Supplements 2023/03
DMSA 2,3-Dimercaptosuccinic acid; 2,3-Dimercaptobutanedioic acid; Succicaptal; Suximer 4: excluded from the supplement definition (201(ff)(3): a drug) Northern Health Products Warning Letter; Nutri-Dyn Midwest, Inc. Warning Letter 2023/04
Doxylamine 2-Dimethylaminoethoxyphenylmethyl -2-picoline 4: excluded from the supplement definition (201(ff)(3): a drug) Arco Globus Trading, LLC et al. Warning Letter 2023/04
Ephedrine alkaloids Ephedrine alkaloid sources include raw botanicals (i.e., plants) and extracts from botanicals:; Ephedra sinica Stapf; Ephedra equisetina Bunge; Ephedra intermedia var. tibetica Stapf 5: fails the safety standard (402(f)(1)(A)) 69 Fed. Reg. 6787 2023/03
Galantamine Galantamine HBr 4: excluded from the supplement definition (201(ff)(3): a drug) Life Enhancement Products, Inc. Warning Letter 2024/02
HCG Human chorionic gonadotropin; APL (hormone); Biogonadil; Follutein 4: excluded from the supplement definition (201(ff)(3): a drug) The hCG Drops, LLC Warning Letter; Theoriginalhcgdrops.com Warning Letter 2023/04
Higenamine Norcoclaurine; Demethylcoclaurine 7: new dietary ingredient with no premarket notification (413(a)(2)) Constituent update and warning letters; Ironmag Labs Warning Letter 2023/03
Higenamine HCl Norcoclaurine HCl; Demethylcoclaurine HCl 3: not a dietary ingredient (201(ff)(1)) Constituent update and warning letters; Advanced Nutritional Supplements LLC Warning Letter 2023/03
Homotaurine Acamprosate; Tramiprosate; 3-Amino-1-propanesulfonic acid; 3-Aminopropanesulphonic acid 3: not a dietary ingredient (201(ff)(1)); 4: excluded from the supplement definition (201(ff)(3): a drug) OVOS Natural Health, Inc. Citizen Petition Response; Chemtech Pharmics, Inc. NDIN 43 Response Letter 2023/04
Hordenine N,N-dimethyltyramine; p-hydroxy-N,N-dimethylphenethylamine; para-hydroxy-N,N-dimethylphenethylamine; 4-hydroxy-N,N-dimethylphenethylamine 7: new dietary ingredient with no premarket notification (413(a)(2)) Constituent update and warning letters; Ironmag Labs Warning Letter 2023/03
Hordenine HCl N,N-dimethyltyramine HCl; p-hydroxy-N,N-dimethylphenethylamine HCl; para-hydroxy-N,N-dimethylphenethylamine HCl; 4-hydroxy-N,N-dimethylphenethylamine HCl 3: not a dietary ingredient (201(ff)(1)) Constituent update and warning letters; Advanced Nutritional Supplements LLC Warning Letter 2023/03
Ibuprofen Advil; Midol; Motrin; Nuprin 4: excluded from the supplement definition (201(ff)(3): a drug) West Coast Laboratories, Inc. Warning Letter; Human Science Foundation Warning Letter 2023/04
Ibutamoren ibutamoren mesylate; MK-677; MK-0677; L-163,191 4: excluded from the supplement definition (201(ff)(3): a drug) Agebox Inc. Warning Letter; Musclepower Enterprise Ltd. dba MONSTER KING and GE LABS Warning Letter 2026/05
Indomethacin Amuno; Indocid; Indocin; Indomet 140 4: excluded from the supplement definition (201(ff)(3): a drug) West Coast Laboratories, Inc. Warning Letter; Human Science Foundation Warning Letter 2023/04
Kratom Kratom; Mitragyna speciosa 2: safety communication; 6: new dietary ingredient fails the safety standard (402(f)(1)(B)) FDA and Kratom; Import Alert 54-15 2023/03
L-DOPA Levodopa; Larodopa; L-3,4-dihydroxyphenylalanine 4: excluded from the supplement definition (201(ff)(3): a drug) RT Naturals, LLC Warning Letter 2023/04
LGD-4033 VK-5211; Anabolicum; Ligandrol 2: safety communication; 4: excluded from the supplement definition (201(ff)(3): a drug) SARMs Safety Communication; Infantry Labs, LLC/1 Nation Nutrition Warning Letter 2024/02
Lorcaserin Belvig; Belviq; AR-10A; APD-356 4: excluded from the supplement definition (201(ff)(3): a drug) HIS Enterprise Inc dba Adam’s Secret USA, LLC Warning Letter 2023/04
Metformin Fluamine; N,N-Dimethyldiguanide; NNDG 4: excluded from the supplement definition (201(ff)(3): a drug) Amrutam Life Care Pvt. Ltd. Cyber Letter 2023/04
Methylsynephrine Oxilofrine; p-hydroxyephedrine; para-hydroxyephedrine; 4-hydroxyephendrine 3: not a dietary ingredient (201(ff)(1)) Methylsynephrine in Dietary Supplements; Constituent update and warning letters 2023/03
N-acetyl-L-cysteine NAC; N-acetylcysteine; Acetyl Cysteine; Acetylcysteine 4: excluded from the supplement definition (201(ff)(3): a drug) Citizen petition response; Guidance for Industry: Policy Regarding N-acetyl-L-cysteine 2023/03
N-Methyltyramine Methyl-4-tyramine; 4-[2-(Methylamino)ethyl]phenol; p-(2-Methylaminoethyl)phenol; 4-Hydroxy-N-methylphenethylamine 7: new dietary ingredient with no premarket notification (413(a)(2)) Carbon Fire, LLC Warning Letter 2024/05
Naproxen Aleve; Anaprox; Methoxypropiocin; Naprosin 4: excluded from the supplement definition (201(ff)(3): a drug) West Coast Laboratories, Inc. Warning Letter; Human Science Foundation Warning Letter 2023/04
Nerium oleander Oleandrin; Corrigen; Foliandrin; Folinerin 2: safety communication; 4: excluded from the supplement definition (201(ff)(3): a drug) Phoenix Biotechnology, Inc. NDIN 1157 Response Letter; Ozelle Pharmaceuticals, Inc NDIN 37 Response Letter 2023/04
Octopamine para-octopamine; p-octopamine; alpha-(Aminoethyl)-p-hydroxybenzyl alcohol; beta-hydroxytyramine 7: new dietary ingredient with no premarket notification (413(a)(2)) Constituent update and warning letters; Max Muscle Warning Letter 2023/03
Ostarine Enobosarm; MK-2866; GTx-024; Ostabolic 2: safety communication; 4: excluded from the supplement definition (201(ff)(3): a drug) SARMs Safety Communication; Infantry Labs, LLC/1 Nation Nutrition Warning Letter 2024/02
Phenibut fenibut; phenigam; PhGaba; PGaba 3: not a dietary ingredient (201(ff)(1)) Phenibut in Dietary Supplements; Constituent update and warning letters 2023/03
Picamilon pikatropin; pikamilon; nicotinyl-gamma-aminobutyric acid; nicotinoyl-GABA 3: not a dietary ingredient (201(ff)(1)) Picamilon in Dietary Supplements; Constituent update and warning letters 2023/03
Piroxicam Feldene; Piroftal; Rosiden; Roxicam 4: excluded from the supplement definition (201(ff)(3): a drug) West Coast Laboratories, Inc. Warning Letter 2023/04
Procysteine Cystox; Oxothiazolidine carboxylate, L-; Koprosteine 4: excluded from the supplement definition (201(ff)(3): a drug) Scientific Systems NDIN 907 Response Letter 2023/04
Pure and Highly Concentrated Caffeine 2: safety communication; 5: fails the safety standard (402(f)(1)(A)) Pure and Highly Concentrated Caffeine; Safety communication 2023/03
Pyridoxamine Pyridoxamine hydrochloride; Pyridoxylamine 4: excluded from the supplement definition (201(ff)(3): a drug) Citizen petition response 2023/03
Red yeast rice Red yeast rice is produced by fermentation of a yeast (Monascus purpureus) on rice. It is a source of monacolins, including monocolin K (also known as lovastatin, the active pharmaceutical ingredient in Mevacor).; Monacolin K; Lovastatin 4: excluded from the supplement definition (201(ff)(3): a drug) Safety communication; Pharmanex, Inc. v. Shalala, 221 F.3d 1151 (10th Cir. 2000) 2023/03
Sarcosine N-methyglycine; Magnesium Sarcosylate; Sarcosine Hydrochloride; Sodium Sarcosinate 4: excluded from the supplement definition (201(ff)(3): a drug) Hsiu-Mei Chao NDIN 389 Response Letter 2023/04
Sibutramine Meridia; Reductil; Didesmethylsibutramine; sibutramine hydrochloride 4: excluded from the supplement definition (201(ff)(3): a drug) X2 Zero Corporation Warning Letter; Shaping Beauty, Inc. Warning Letter 2023/04
Sildenafil Acetildenafil; Desmethyl Sildenafil; Homosildenafil; Hydroxyhomosildenafil 4: excluded from the supplement definition (201(ff)(3): a drug) Thirsty Run LLC / US Royal Honey LLC Warning Letter; MS Bionic Warning Letter 2023/04
Sulbutiamine sulbutiamina; sulbutiaminum; arcalion; bisibuthiamine 3: not a dietary ingredient (201(ff)(1)) Gluten Free Remedies LLC Warning Letter 2025/05
Tadalafil Cialis; Adcirca 4: excluded from the supplement definition (201(ff)(3): a drug) 1am USA Incorporated dba Pleasure Products USA Warning Letter; MS Bionic Warning Letter 2023/04
Terazosin Blavin; Flumarc; Fosfomic; Vasomet 4: excluded from the supplement definition (201(ff)(3): a drug) USA Far Ocean Group Inc./Health & Beauty Group Inc. Warning Letter 2023/04
Tianeptine Tianeptine sulfate; Tianeptine sodium powder; Tianeptine acid 2: safety communication; 3: not a dietary ingredient (201(ff)(1)) Tianeptine in Dietary Supplements; Health Fraud Scams – Tianeptine 2023/03
Vardenafil Levitra; Staxyn; Vivanza 4: excluded from the supplement definition (201(ff)(3): a drug) Biogenix USA, LLC Warning Letter 2023/04

61 of 84 directory entries. Category counts across the directory: 1: 13 · 2: 19 · 3: 14 · 4: 37 · 5: 2 · 6: 4 · 7: 6 (an entry can carry more than one code). Category wording is FDA’s: (3) Ingredient is not a "dietary ingredient" under section 201(ff)(1) of the FD&C Act; (4) Ingredient is excluded from the dietary supplement definition under section 201(ff)(3) of the FD&C Act; (5) Dietary ingredient has not met the safety standard in section 402(f)(1)(A) of the FD&C Act; (6) New dietary ingredient has not met the safety standard in section 402(f)(1)(B) of the FD&C Act; (7) New dietary ingredient requiring a premarket safety notification under section 413(a)(2) of the FD&C Act but for which no notification has been submitted.

The other 23 directory entries: health-claim letters and safety communications (not bans)
IngredientFDA status (category)FDA actionListed / updated
Acadibol 2: safety communication SARMs Safety Communication 2024/02
Andarine 2: safety communication SARMs Safety Communication 2025/12
Biotin 2: safety communication Safety communication 2023/03
Calcium 1: health claim (not a ban) Health claims: calcium, vitamin D, and osteoporosis; Qualified Health Claims: Letter Regarding Calcium and Colon/Rectal, Breast, and Prostate Cancers and Recurrent Colon Polyps 2023/04
Calcium in combination with Vitamin D 1: health claim (not a ban) Health claims: calcium, vitamin D, and osteoporosis 2023/04
Chromium Picolinate 1: health claim (not a ban) Qualified Health Claims: Letter of Enforcement Discretion – Chromium Picolinate and Insulin Resistance 2023/04
Comfrey 2: safety communication Safety communication 2023/03
Eicosapentaenoic Acid and Docosahexaenoic Acid in combination 1: health claim (not a ban) Qualified Health Claims: Letter Re Eicosapentaenoic Acid and Docosahexaenoic Acid and Reduction of Blood Pressure in the General Population; Qualified Health Claims: Letter re EPA and DHA and Reduced Risk of Coronary Heart Disease 2023/04
Folic Acid 1: health claim (not a ban) Health claims: Folate and neural tube defects; Qualified Health Claims: Letter regarding disclaimers for comparative folic acid and neural tube defects claim 2023/04
Folic Acid in combination with Vitamin B6 and Vitamin B12 1: health claim (not a ban) Qualified Health Claims: Settlement Re Claim Relating to B Vitamins and Vascular Disease 2023/04
Kava 2: safety communication Safety communication 2023/03
Magnesium 1: health claim (not a ban) Constituent update and enforcement letter regarding qualified health claim 2023/04
Phosphatidylserine 1: health claim (not a ban) Qualified Health Claims: Update Re Phosphatidylserine and Cognitive Function and Dementia; Qualified Health Claims: Letter Re Phosphatidylserine and Cognitive Dysfunction and Dementia 2023/04
Plant stanol esters 1: health claim (not a ban) Health claims: plant sterol/stanol esters and risk of coronary heart disease (CHD) 2023/04
Psyllium husk 1: health claim (not a ban) Qualified Health Claims: Psyllium Husk and a Reduced Risk of Type 2 Diabetes 2023/04
RAD-150 2: safety communication SARMs Safety Communication 2024/02
S-23 2: safety communication SARMs Safety Communication 2024/02
Testolone 2: safety communication SARMs Safety Communication 2024/02
Vinpocetine 2: safety communication Vinpocetine in Dietary Supplements 2023/03
Vitamin B12 in combination with Folic Acid and Vitamin B6 1: health claim (not a ban) Qualified Health Claims: Settlement Re Claim Relating to B Vitamins and Vascular Disease 2023/04
Vitamin B6 in combination with Folic Acid and Vitamin B12 1: health claim (not a ban) Qualified Health Claims: Settlement Re Claim Relating to B Vitamins and Vascular Disease 2023/04
Vitamin D in combination with calcium 1: health claim (not a ban) Health claims: calcium, vitamin D, and osteoporosis 2023/04
YK-11 2: safety communication SARMs Safety Communication 2024/02

List 2: products FDA found to contain a hidden drug

SourceFDA, Health Fraud Product Database (the successor of the “Tainted Products Marketed as Dietary Supplements” list; the old address redirects here), fetched 2026-09-21. The database holds 2,202 rows across every FDA program; we keep the 1,406 whose subject names an undeclared or hidden ingredient, and classify each by that ingredient. FDA itself warns the list “only includes a small fraction of the potentially hazardous products marketed to consumers”.

Hidden-ingredient type (our classification)NotificationsTypical hidden drugs
sexual enhancement802sildenafil, tadalafil, vardenafil and unapproved analogues (sulfoaildenafil, aminotadalafil)
weight loss428sibutramine, phenolphthalein, fluoxetine, lorcaserin
muscle building93anabolic steroids (Superdrol, Madol, Tren), SARMs, androstenedione
other136NSAIDs (diclofenac), corticosteroids (dexamethasone), yellow oleander, other drugs
Most-named hidden ingredientsRows
sildenafil458
sibutramine350
tadalafil261
phenolphthalein98
superdrol89
steroids88
madol88
androstenedione88
turinabol88
sulfoaildenafil86
tren83
diclofenac56

Notifications by year: 2007: 15 · 2008: 83 · 2009: 137 · 2010: 71 · 2011: 42 · 2012: 47 · 2013: 95 · 2014: 99 · 2015: 129 · 2016: 81 · 2017: 98 · 2018: 73 · 2019: 66 · 2020: 70 · 2021: 33 · 2022: 38 · 2023: 45 · 2024: 76 · 2025: 44 · 2026: 64. The year-to-year swings track FDA’s enforcement sweeps (import screening and online purchases), not the size of the market.

Every notification since 2025-01-01 (108 products)

DateProductHidden ingredient(s)TypeSold viaFDA action
2026-09-15 LUZE Fit sibutramine weight loss shop.app Public Notification
2026-09-15 Beauty 911 sibutramine weight loss shop.app Public Notification
2026-09-15 DEEP amino tadalafil sexual enhancement Various Distributors Public Notification
2026-09-04 ZUBB Dietary Supplement sildenafil sexual enhancement International Mail Shipments Public Notification
2026-09-02 MAXMAN Coffee sildenafil, tadalafil sexual enhancement Various Distributors Public Notification
2026-08-25 Qu Feng Huo Lou Dan dexamethasone other newgreenusa.com Public Notification
2026-08-18 Esbelta Chupapanza Flat Belly phenolphthalein weight loss elegantfigure.com Public Notification
2026-08-18 Esbelta Intense Loss sibutramine, desmethyl sibutramine, benzyl sibutramine, sildenafil sexual enhancement, weight loss elegantfigure.com Public Notification
2026-08-12 Premium OrgaZEN 10000 sildenafil sexual enhancement Public Notification
2026-08-12 Anaconda Premium 500K tadalafil sexual enhancement Public Notification
2026-08-12 DMagic Plus diclofenac, neriifolin, thevetin B other lamilagrosalab.com Public Notification
2026-08-12 B. MAGI phenolphthalein, neriifolin, thevetin B weight loss lamilagrosalab.com Public Notification
2026-07-23 Kangaroo Intense Venus 3000 sildenafil sexual enhancement usroyalhoney.com Public Notification
2026-07-14 Xian Ling tapentadol, meloxicam other Various Distributors Public Notification
2026-07-14 Detoxi Slim
People's Bazaar II
sibutramine weight loss International Mail Shipments Public Notification
2026-07-01 MAGNUM XXL 300K Honey sildenafil, tadalafil sexual enhancement Various Distributors Public Notification
2026-06-24 PRE-FORMANCE BLACK 1, 4-dimethylamylamine, DMAA weight loss advancedsupps.com Public Notification
2026-06-10 Branch Manager for Men yohimbine sexual enhancement supplx.com Public Notification
2026-06-10 Business Pill yohimbine sexual enhancement supplx.com Public Notification
2026-06-05 Pink Pussycat brand products sildenafil, tadalafil sexual enhancement Various websites Public Notification
2026-06-04 Lipofit Extreme 2.0 Fat Burner
Ana Salazar Modela Tu Cuerpo Inc.
fluoxetine, 2, 4-dinitrophenol (DNP) weight loss anasalazar.us.com Public Notification
2026-06-04 Juicy AF! sildenafil sexual enhancement Various Distributors Public Notification
2026-05-29 Taewon Liar
Bella's Nutri Shop
meloxicam, ketorolac, dexamethasone, tapentadol other bproductline.com; etsy.com Public Notification
2026-05-29 Baipho Herbs Tea Drink piroxicam other amazon.com Public Notification
2026-05-29 Big Dick Energy! tadalafil sexual enhancement Various Distributors Public Notification
2026-05-29 X10 Natural Enhancement Supplement
A&P Creations LLC
sildenafil, tadalafil sexual enhancement naturefuel.us Public Notification
2026-05-29 Erectus Plus sildenafil, tadalafil, testosterone propionate sexual enhancement, muscle building ebay.com Public Notification
2026-05-29 Sensual Miracle Honey sildenafil, tadalafil sexual enhancement Various Distributors Public Notification
2026-05-28 Better Weather Fix Elixir 15 ml
Better Weather Activities LLC
Mitragynine, Mitragynine Pseudoindoxyl (Kratom) other Recall
2026-05-27 biQ-FEL
A&P Creations LLC
sildenafil, tadalafil sexual enhancement walmart.com; biqfelusa.com Public Notification
2026-05-15 Sâm Xương Khớp Ông Tiên piroxicam, dexamethasone phosphate other ongtienlinhchi.com Public Notification
2026-05-11 Better Weather Fix Elixir products
XD Investments LLC
Mitragynine, Mitragynine Pseudoindoxyl (Kratom) other Recall
2026-05-07 Hard AF! sildenafil, tadalafil sexual enhancement Various Distributors Public Notification
2026-05-05 RAPTURE Preworkout 1, 3-dimethylamylamine (DMAA) weight loss leaderformulas.com Public Notification
2026-04-24 New Hyaluronic Acid 850 mg Sealed 30 Caps, Umary
ibeautistore.com
diclofenac, dexamethasone, omeprazole other ibeautistore.com Public Notification
2026-04-07 Yeicob Ácido Hialurónico
Ray's Vitamins
dexamethasone phosphate, diclofenac other raysvitamins.com Public Notification
2026-04-07 KUKA FLEX CBD diclofenac other ebay.com Public Notification
2026-04-07 DINA Acido Hialurónico dexamethasone, methocarbamol, meloxicam, phenolphthalein weight loss ebay.com Public Notification
2026-04-07 RM Joe dexamethasone phosphate, diclofenac other naturistamexicanstore.com Public Notification
2026-04-07 Curcuflex dexamethasone, diclofenac other ebay.com Public Notification
2026-04-07 Umary
Various
diclofenac, dexamethasone, omeprazole other solovital.com; Main Products, Inc.; ebay.com Public Notification
2026-04-06 WAP Sensual Enhancement
Best Supplements Best Prices
sildenafil, tadalafil, flibanserin sexual enhancement ebay.com Public Notification
2026-04-03 Addall XR Shot
ZMB Enterprises, LLC
2-amino-6-methylheptane (DMHA), undeclared 1, 4-DMAA weight loss Alert
2026-04-03 Addall-brand dietary supplement
ZMB Enterprises, LLC
Phenibut (β-phenyl-GABA), undeclared 1, 4-DMAA (1, 4-dimethylamylamine) weight loss Alert
2026-03-26 Gold Lion Aphrodisiac Chocolate Sachet
Gear Isle
sildenafil, tadalafil sexual enhancement Gear Isle Recall
2026-03-14 Boner Bear Honey
Pure Vitamins and Natural Supplements, LLC
sildenafil, tadalafil sexual enhancement Recall
2026-03-14 Red Bull Extreme
Pure Vitamins and Natural Supplements, LLC
sildenafil sexual enhancement Recall
2026-03-14 Blue Bull Extreme
Pure Vitamins and Natural Supplements, LLC
sildenafil sexual enhancement Recall
2026-03-13 Kian Pee Wan
Aphreseller
dexamethasone, cyproheptadine other ebay.com; buy-herbal.com Public Notification
2026-03-11 Chupa Panza
Naturista Reyes (Suerte Y Salud LLC, La Tia Mana LLC)
yellow oleander other ebay.com Alert
2026-03-03 Artri Ajo Rey dexamethasone, diclofenac, methocarbamol other naturistarex.com Public Notification
2026-02-26 ULTRA ADVANC3 GOLD dexamethasone, diclofenac, methocarbamol other naturistarex.com Public Notification
2026-02-26 ULTRA ADVANC3 dexamethasone, diclofenac, methocarbamol other amazon.com Public Notification
2026-02-13 Green Lumber (update)
Green Lumber Holdings LLC
tadalafil sexual enhancement getgreenlumber.com, greenlumber.com Public Notification
2026-02-13 LOVION Chocolate with Ginseng for Men sildenafil, tadalafil sexual enhancement lovionusa.com Public Notification
2026-02-13 Fantasy Aphrodisiac Chocolate sildenafil sexual enhancement gearisle.com Public Notification
2026-02-13 DTF Sexual Chocolate
Nalpac
sildenafil, tadalafil sexual enhancement shopsexology.com Public Notification
2026-02-13 Boner Bears Chocolate Syrup
Lockout Supplements
sildenafil sexual enhancement lockoutsupplements.com Public Notification
2026-02-13 Boner Bears Chocolate Bar
JXK Enterprises, Inc
sildenafil sexual enhancement elyxr.com Public Notification
2026-02-11 Pink Pussycat Aphrodisiac Chocolate tadalafil sexual enhancement loverslane.com Public Notification
2026-02-11 Rhino Choco VIP
USA LESS Co.
tadalafil sexual enhancement usaless.com Public Notification
2026-02-11 ilum Male Sexual Enhancement Chocolate
Gear Isle
sildenafil, tadalafil sexual enhancement ebay.com; Gear Isle Public Notification
2026-02-03 Ashfiat Alharamain
Akkarco LLC
tadalafil sexual enhancement akkarco.com; amazon.com Recall
2026-01-09 Modern Warrior Ready
Modern Warrior
tianeptine, 1, 4-DMAA, aniracetam weight loss Recall
2025-12-02 GE Labs Ykarine
GE Labs LLC
trendione (estra-4, 9, 11-triene-3, 17-dione) other monsterking.eu Alert
2025-11-21 mR.7 SUPER 700000
StuffbyNainax LLC
sildenafil, tadalafil sexual enhancement ebay.com Public Notification
2025-11-03 SiluetaYa Mexican Tejocote Roots
SiluetaYa, LLC
yellow oleander other siluetayausa.com Recall
2025-11-03 SdB ELITE
OBC Group Corp
yellow oleander other naturalvida.com Alert
2025-11-03 SdB Semilla de Brasil Tejocote Root
OBC Group Corp
yellow oleander other ebay.com Alert
2025-10-23 SPARTAN sildenafil sexual enhancement vroxusa.com Public Notification
2025-10-23 vROX sidenafil sexual enhancement vroxusa.com Public Notification
2025-10-17 Black Thai Honey sildenafil, tadafil, diclofenac sexual enhancement honeypack.com Public Notiication
2025-10-17 Ashfiat Alharamain Energy Support tadalafil sexual enhancement amazon.com Public Notification
2025-10-06 Osteo Sin Max dexamethasone, methocarbamol, phenylbutazone other ebay.com Public Notification
2025-10-06 Mojo Max Fusion XXX sildenafil, tadalafil sexual enhancement ebay.com Public Notification
2025-10-03 Contra Reumas dexamethasone, diclofenac, methocarbamol other naturistarex.com Public Notification
2025-09-30 Me Vale Madre acetaminophen, diclofenac other ebay.com Public Notification
2025-09-23 Agebox iKids Growth Day Formula ibutamoren muscle building agebox.com Public Notification
2025-09-23 Agebox iKids Growth Night Formula ibutamoren muscle building agebox.com Public Notification
2025-09-23 Flexi Bion dexamethasone, diclofenac other ebay.com Public Notification
2025-09-23 SILINTAN
123Herbals
meloxicam other 123herbals.com Public Notification
2025-09-18 Primal Herbs Volume
Primal Supplements Group LLC
sildenafil sexual enhancement primalherbs.com Public Notification
2025-09-05 FTX PLUS dexamethasone phosphate, diclofenac other walmart.com Public Notification
2025-09-05 REUMA KING dexamethasone, diclofenac, methocarbamol other etsy.com Public Notification
2025-08-22 PAIN FLEX
NaTerra
dexamethasone, methocarbamol other amazon.com Public Notification
2025-07-22 FATZorb
Beauty Collection International Pte Ltd
sibutramine, desmethyl sibutramine, benzyl sibutramine, phenolphthalein sexual enhancement, weight loss ebay.com Public Notification
2025-07-08 Versace Real Honey for Men
Sekerciler Tic. ve San. Ltd. Sti.
sildenafil, tadalafil, acetaminophen sexual enhancement Various websites Public Notification
2025-07-08 Black Horse Miracle Honey for Men
Sekerciler Tic. ve San. Ltd. Sti.
sildenafil, tadalafil sexual enhancement Various websites Public Notification
2025-07-08 Secret Miracle Honey Extra Strength
Sekerciler Tic. ve San. Ltd. Sti.
sildenafil, tadalafil, acetaminophen sexual enhancement Various websites Public Notification
2025-07-08 Black Panther Miracle Honey for Men
Sekerciler Tic. ve San. Ltd. Sti.
sildenafil, tadalafil, acetaminophen sexual enhancement Various websites Public Notification
2025-06-24 Toki Slimming Candy
Hoang Huy Investment & Trading Co., Ltd.
sibutramine weight loss ebay.com Public Notification
2025-05-15 Dolotrex
Innovacion Natural
diclofenac other innvocaionnatural.com Public Notification
2025-05-15 Umovy
EREN NATURALS SA DE CV
dexamethasone, diclofenac other umovy-usa.com Public Notification
2025-05-15 Unavy
EREN NATURALS SA DE CV
dexamethasone, diclofenac, omeprazole other umary-usa.com Public Notification
2025-05-06 Endurance Boost
EnShiShiXiangNiShangMaoYouXianGongSi
propoxyphenylsildenafil, sildenafil sexual enhancement amazon.com Recall
2025-04-25 Male Ultra Pro
Health Fixer
chloropretadalafil, propoxyphenylsildenafil, sildenafil sexual enhancement amazon.com Recall
2025-04-25 Ultra Armor
Health Fixer
chloropretadalafil, propoxyphenylsildenafil, sildenafil sexual enhancement amazon.com Recall
2025-04-25 Electro Buzz
Health Fixer
chloropretadalafil, propoxyphenylsildenafil, sildenafil sexual enhancement amazon.com Recall
2025-04-25 Malextra
Health Fixer
chloropretadalafil, propoxyphenylsildenafil, sildenafil sexual enhancement amazon.com Recall
2025-04-25 Male Ultra
Health Fixer
chloropretadalafil, propoxyphenylsildenafil, sildenafil sexual enhancement amazon.com Recall
2025-04-25 Artrifan King
Omega Nutrition
dexamethasone, diclofenac, methocarbamol other artriking.us Public Notification
2025-04-23 Pain Flex Forte
NaTerra
dexamethasone, diclofenac other ibspot.com Public Notification
2025-02-10 ADVANCE KING dexamethasone, diclofenac, methocarbamol other naturistastore.com Public Notification
2025-02-10 bio LIT 1, 4-dimethylamylamine (DMAA) weight loss Various websites Public Notification
2025-02-10 Special Edition Platinum 10K acetaminophen, tadalafil, vardenafil sexual enhancement Various websites Public Notification
2025-02-10 vROX sildenafil sexual enhancement Various websites Public Notification
2025-02-10 HimGo sildenafil sexual enhancement ebay.com Public Notification
2025-02-10 VITALITY
One Source Nutrition
sildenafil, tadalafil sexual enhancement zen-herbs.com Public Notification

Older rows (1,298 products, 2007–2024) are in the open-data file. Each row’s FDA action link is the source for that row.

List 3: DoD prohibited dietary supplement ingredients

SourceOperation Supplement Safety (Uniformed Services University), DoD Prohibited Dietary Supplement Ingredients, prepared under DoD Instruction 6130.06. The page is a search box over an API with no download or published total; we crawled it on 2026-09-21 with 3,000 queries and reached 850 ingredient entries (4,420 names including synonyms). The crawl hit its request budget before the queue was empty, so the count is a lower bound, not the whole list. OPSS states the list was last updated on 26 May 2026.

Service members are prohibited from using any substance in this database as a supplement ingredient, and separately from all controlled substances and drugs. The reasons OPSS attaches to entries, by count: DEA Controlled Substance List: Schedule I (283), DEA Controlled Substance List: Schedule III (110), WADA S1: Anabolic Agents (110), DEA Controlled Substance List: Schedule IV (80), DEA Controlled Substance List: Schedule II (62), Prescription drug (62).

IngredientAlso listed asReasonReference
1-(1-phenylcyclohexyl)-pyrrolidine PCPy; PHP; rolicyclidine; pyrrolidine analog of phencyclidine; 1-(1-Phenylcyclohexyl)pyrrolidine DEA Controlled Substance List: Schedule I OPSS entry
1-(5-fluoropentyl)-3-(1-naphthoyl)indole AM2201; AM-2201; AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) DEA Controlled Substance List: Schedule I OPSS entry
1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole AM-694; AM694 DEA Controlled Substance List: Schedule I OPSS entry
1-[1-(2-thienyl)cyclohexyl]piperidine TPCP; 1-[1-(2-thienyl)-cyclohexyl]-piperidine; TCP; thiophene analog of phencyclidine; 2-thienylanalog of phencyclidine (+1) DEA Controlled Substance List: Schedule I OPSS entry
1-[1-(2-thienyl)cyclohexyl]pyrrolidine TCPy DEA Controlled Substance List: Schedule I OPSS entry
1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole JWH-200; JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- naphthoyl)indole) DEA Controlled Substance List: Schedule I OPSS entry
1-androstenediol 3β,17β-dihydroxy-5α-androst-1-ene; 3alpha,17beta-dihydroxy-5alpha-androst-1-ene; 3beta,17beta-dihydroxy-5alpha-androst-1-ene; 5α-androst-1-ene-3β,17β-diol; 5alpha-androst-1-ene-3beta,17beta-diol (+1) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
1-androstenedione 5ɑ-androst-1-ene-3ß, 17ß-dione; 5α-androst-1-ene-3,17-dione; [5α]-androst-1-en-3,17-dione; 5alpha-androst-1-ene-3,17-dione DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
1-androsterone androst-1-en-17-one, 3-hydroxy-, (3β,5α)-; 1-androstenolone; (3beta,5alpha)-3-hydroxyandrost-1-en-17-one; 3β-hydroxy-5α-androsta-1-ene-17-one; 1-androstene-3beta-ol, 17-one (+24) WADA S1: Anabolic Agents OPSS entry
1-butyl-3-(1-naphthoyl)indole JWH-073; JWH-073 (1-Butyl-3-(1-naphthoyl)indole) DEA Controlled Substance List: Schedule I OPSS entry
1-hexyl-3-(1-naphthoyl)indole JWH-019; JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) DEA Controlled Substance List: Schedule I OPSS entry
1-pentyl-3-(1-naphthoyl)indole AM-678; AM678; JWH-018 (also known as AM678) (1-Pentyl-3-(1- naphthoyl)indole); JWH-018 DEA Controlled Substance List: Schedule I OPSS entry
1-pentyl-3-(2-chlorophenylacetyl)indole 2-(2-chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone; JWH-203; JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) DEA Controlled Substance List: Schedule I OPSS entry
1-pentyl-3-(2-methoxyphenylacetyl)indole 2-(2-methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone; JWH-250 DEA Controlled Substance List: Schedule I OPSS entry
1-pentyl-3-(4-chloro-1-naphthoyl)indole JWH-398; (4-chloronaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone; JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) DEA Controlled Substance List: Schedule I OPSS entry
1-pentyl-3-(4-methyl-1-naphthoyl)indole (4-methylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone; JWH-122; JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) DEA Controlled Substance List: Schedule I OPSS entry
1-pentyl-3-[1-(4-methoxynaphthoyl)]indole 1-pentyl-3-(4-methoxynaphthoyl)indole; JWH-081; (4-methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone; JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)indole) DEA Controlled Substance List: Schedule I OPSS entry
1-phenylcyclohexylamine 1-phenylcyclohexan-1-amine DEA Controlled Substance List: Schedule II OPSS entry
1-testosterone 1-Testo; 17β-hydroxy-5α-androst-1-en-3-one; Δ1-dihydrotestosterone (17β-hydroxy-5α-androst-1-en3-one); Δ1-dihydrotestosterone; 1-testosterone acetate (+2) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
11-keto-testosterone 17beta-hydroxy-androst-4-en-3,11-one; 17β-Hydroxy-androst-4-en-3,11-one WADA S1: Anabolic Agents; DoDI 1010.16 OPSS entry
11β-methyl-19-nortestosterone 11β-methylestr-4-en-17β-ol-3-one; 11beta-methylestr-4-en-17beta-ol-3-one; 11β-MNT; 11beta-MNT; 11beta-methyl-19-nortestosterone (+1) WADA S1: Anabolic Agents OPSS entry
13β-ethyl-17β-hydroxygon-4-en-3-one 18-methyl-19-nortestosterone; 13beta-ethyl-17beta-hydroxygon-4-en-3-one; 17beta-hydroxy-13-ethylgon-4-en-3-one DEA Controlled Substance List: Schedule III OPSS entry
17-dihydroexemestane 17beta-hydroxy exemestane; 17β-hydroxy exemestane; methylene boldenone; 6-methylene-17-hydroxyandrosta-1,4-diene-3-one; androsta-1,4-dien-3-one, 17-hydroxy-6-methylene- (+4) WADA S4: Hormone and Metabolic Modulators OPSS entry
17alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane 17-methyl-5α-androstane-3β,17β-diol; 17-methyl-5alpha-androstane-3beta,17beta-diol; 17α-methyl-3β,17β-dihydroxy-5α-androstane DEA Controlled Substance List: Schedule III OPSS entry
17alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene 17-methyl-androst-4-ene-3beta,17beta-diol; 17-methyl-androst-4-ene-3β,17β-diol; 17-methylandrost-4-ene-3beta,17beta-diol; 17-methylandrost-4-ene-3β,17β-diol; 17α-methyl-3β,17β-dihydroxyandrost-4-ene DEA Controlled Substance List: Schedule III OPSS entry
17alpha-methyl-4-hydroxynandrolone 17alpha-methyl-4-hydroxy-17beta-hydroxyestr-4-en-3-one; 4-hydroxy-19-normethyltestosterone; 17α-methyl-4-hydroxynandrolone; estr-4-en-3-one, 4,17β-dihydroxy-17-methyl-; 17α-methyl-4-hydroxy-17β-hydroxyestr-4-en-3-one (+2) DEA Controlled Substance List: Schedule III OPSS entry
17alpha-methyl-5alpha-androstan-17beta-ol protobol; 17a-methyl-5a-androst-17b-ol; 17-methyl-5α-androstan-17β-ol; 17α-methyl-5α-androstan-17β-ol; protodrol (+1) DEA Controlled Substance List: Schedule III OPSS entry
17alpha-methyl-androst-2-ene-3,17beta-diol 17α-methyl-androst-2-ene-3,17β-diol; 17a-methyl-androst-2-ene-3,17b-diol DEA Controlled Substance List: Schedule III OPSS entry
17alpha-methyl-androsta-1,4-diene-3,17beta-diol 17a-methyl-1,4-androstadiene-3,17diol; 17alpha-methyl-1,4-androstadiene-3,17diol; methyl-1,4AD; 17α-methyl-1,4-androstadiene-3,17diol; M1,4ADD (+6) DEA Controlled Substance List: Schedule III OPSS entry
17alpha-methyl-androstan-3-hydroxyimine-17beta-ol 17α-methyl-androstan-3-hydroxyimine-17β-ol; 17a-Methyl-androstan-3-hydroxyimine-17b-ol DEA Controlled Substance List: Schedule III OPSS entry
17beta-hydroxy-androstano[2,3-d]isoxazole 17β-hydroxy-androstano[2,3-d]isoxazole; 17b-Hydroxy-androstano[2,3-d]isoxazole DEA Controlled Substance List: Schedule III OPSS entry
17beta-hydroxy-androstano[3,2-c]isoxazole 17β-hydroxy-androstano[3,2-c]isoxazole; 17b-Hydroxy-androstano[3,2-c]isoxazole DEA Controlled Substance List: Schedule III OPSS entry
18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one DEA Controlled Substance List: Schedule III OPSS entry
19-nor-4,9(10)-androstadienedione methyldienedione; estra-4,9-diene-3,17-dione; 4,9-esteadine-3,17-dione; estra-4,9-dien-3,17-dione; dienedione (+8) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
19-nor-5-androstenediol 3alpha,17beta-dihydroxyestr-5-ene; 3α, 17β-dihydroxyestr-5-ene; 3β, 17β-dihydroxyestr-5-ene; 3beta,17beta-dihydroxyestr-5-­ene DEA Controlled Substance List: Schedule III OPSS entry
19-nor-5-androstenedione 19-norandrost-5-en-3,17-dione; 19-norandrost-5-ene-3,17-dione; estr-5-en-3,17-dione; estr-5-ene-3,17-dione DEA Controlled Substance List: Schedule III OPSS entry
19-norandrosterone 5α-estran-3α-ol-17-one; 19-nor-androsterone; 3alpha-hydroxy-5alpha-estran-17-one; 3α-hydroxy-5α-estran-17-one; 5alpha-estran-3alpha-ol-17-one WADA S1: Anabolic Agents OPSS entry
2',5'-dimethoxyfentanyl N-(1-(2,5- dimethoxyphenethyl)piperidine-4-yl)-N-phenylpropionamide; N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide DEA Controlled Substance List: Schedule I OPSS entry
2,5-dimethoxyamphetamine 2,5-dimethoxy-alpha-methylphenethylamine; 2,5-dimethoxy-α-methylphenethylamine; 2,5-DMA; DMA DEA Controlled Substance List: Schedule I OPSS entry
2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one 2-(3-dethoxyphenyl)-2-(N-ethylamino)cyclohexanone; 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone; 2-(3-methoxyphenyl)-2-(N-ethylamino)cyclohexanone; 2-(ethylamino)-2-(3-methoxyphenyl)-1-cyclohexanone; 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexanone (+6) DEA Controlled Substance List: Schedule I OPSS entry
2-androstenol 5alpha-androst-2-en-17-ol; 5α-androst-2-en-17-ol WADA S4: Hormone and Metabolic Modulators OPSS entry
2-androstenone 17-oxo-5α-androst-2-ene; 17-oxo-5a-androst-2-ene; 5 α androst-2-en- 17-one; 17-oxo-5alpha-androst-2-ene; delta-2 (+5) WADA S4: Hormone and Metabolic Modulators OPSS entry
2-Phenylbenzo[h]chromen-4-one 7,8-benzoflavone; 2-phenylbenzo[h]chromen-4-one; alpha-naphthoflavone; ɑ-naphthoflavone WADA S4: Hormone and Metabolic Modulators OPSS entry
25B-NBOMe 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine; Cimbi-36; 2C-B-NBOMe; 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) DEA Controlled Substance List: Schedule I OPSS entry
25C-NBOMe 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine; 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine; 2C-C-NBOMe; Cimbi-82; 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) DEA Controlled Substance List: Schedule I OPSS entry
25I-NBOMe Cimbi-5; 2C-I-NBOMe; 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine; 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe) DEA Controlled Substance List: Schedule I OPSS entry
2C-C 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine; 2-(4-chloro-2,5-dimethoxyphenyl) ethanamine; 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) DEA Controlled Substance List: Schedule I OPSS entry
2C-D 2-(2,5-dimethoxy-4-methylphenyl) ethanamine; 2-(2,5-dimethoxy-4-methylphenyl)ethanamine; 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) DEA Controlled Substance List: Schedule I OPSS entry
2C-E 2,5-Dimethoxy-3,4-dimethylphenethylamine (2C-G); 2-(2,5-dimethoxy-4-ethylphenyl) ethanamine; 2-(2,5-dimethoxy-4-ethylphenyl)ethanamine; 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E) DEA Controlled Substance List: Schedule I OPSS entry
2C-H 2-(2,5-dimethoxyphenyl)ethanamine; 2-(2,5-dimethoxyphenyl) ethanamine; 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) DEA Controlled Substance List: Schedule I OPSS entry
2C-I 2-(4-iodo-2,5-dimethoxyphenyl)ethanamine; 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine; 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) DEA Controlled Substance List: Schedule I OPSS entry
2C-N 2-(2,5-dimethoxy-4-nitro-phenyl) ethanamine; 2-(2,5-dimethoxy-4-nitro-phenyl)ethanamine; 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) DEA Controlled Substance List: Schedule I OPSS entry
2C-P 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2-CP); 2-(2,5-dimethoxy-4-(n)-propylphenyl)ethanamine; 2-(2,5-dimethoxy-4-(n)-propylphenyl) ethanamine DEA Controlled Substance List: Schedule I OPSS entry
2C-T-2 2-[4-(ethylthio)-2,5-dimethoxyphenyl] ethanamine; 2-[4-(ethylthio)-2,5-dimethoxyphenyl]ethanamine; 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2) DEA Controlled Substance List: Schedule I OPSS entry
2C-T-4 2,5-Dimethoxy-4-ethylthioamphetamine; 2-[4-(isopropylthio)-2,5-dimethoxyphenyl]ethanamine; 2,5-Dimethoxy-4-ethylthioamphetamine (Aleph-2); Aleph-2; 2-[4-(isopropylthio)-2,5-dimethoxyphenyl] ethanamine (+1) DEA Controlled Substance List: Schedule I OPSS entry
2C-T-7 2,5-dimethoxy-4(n)-propylthiophenethylamine; 2,5-dimethoxy-4-(n)-propylthiophenethylamine; 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) DEA Controlled Substance List: Schedule I OPSS entry
2′-fluoro ortho-fluorofentanyl 2'-Fluoro ortho-fluorofentanyl (N-(1-(2- fluorophenethyl)piperidin-4-yl)-N-(2- fluorophenyl)propionamide; also known as 2'-fluoro 2- fluorofentanyl); N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; 2′-fluoro 2-fluorofentanyl DEA Controlled Substance List: Schedule I OPSS entry
3,4-dimethylmethcathinone 3,4-DMMC DEA Controlled Substance List: Schedule I OPSS entry
3-androstenol 3-Androstenol (5ɑ-androst-3-en-17-ol); 5α-androst-3-en-17-ol; 5alpha-androst-3-en-17-ol WADA S4: Hormone and Metabolic Modulators OPSS entry
3-fluoro-N-methylcathinone 3-FMC; 1-(3-fluorophenyl)-2-(methylamino)propan-1-one); 3-Fluoro-N-methylcathinone (3-FMC) DEA Controlled Substance List: Schedule I OPSS entry
3-furanyl fentanyl N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide; N-(1-phenthylpiperidin-4-yl)-N-phenylfuran-3-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
3-methylethcathinone 3-MEC DEA Controlled Substance List: Schedule I OPSS entry
3-methylfentanyl 3-MF; mefentanyl; China White; N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide DEA Controlled Substance List: Schedule I OPSS entry
3-methylthiofentanyl N-(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl)-N-phenylpropanamide; N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide; 3-methyl-thiofentanyl DEA Controlled Substance List: Schedule I OPSS entry
3beta-hydroxy-estra-4,9,11-trien-17-one 3β-hydroxy-estra-4,9,11-trien-17-one; 3b-hydroxy-estra-4,9,11-trien-17-one DEA Controlled Substance List: Schedule III OPSS entry
4'-chloro-alpha-PVP 4'-chloro-α-pyrrolidinopentiophenone; 4-chloro-a-PVP; 4'-chloro-α-pyrrolidinovalerophenone; 4-chloro-α-PVP; 4'-chloro-alpha-pyrrolidinopentiophenone (+3) DEA Controlled Substance List: Schedule I OPSS entry
4,4′-Dimethylaminorex 4,5-Dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4,4′-DMAR; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine DEA Controlled Substance List: Schedule I OPSS entry
4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2- F][1,2,4]triazolo[4,3-A][1,4]diazepine etizolam DEA Controlled Substance List: Schedule I OPSS entry
4-androstene-3,6,17 trione 4-Androstene-3,6,17-trione; 6-oxo-androstenedione; 4-androsten-3,6,17-trione; 6-oxo; 4-AT (+2) WADA S4: Hormone and Metabolic Modulators OPSS entry
4-androstenediol 3beta,17beta-dihydroxy-androst-4-ene; androst-4-ene-3β,17β-diol; 3β,17β-dihydroxy-androst-4-ene DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
4-anilino-N-phenethylpiperidine 4-anilino-N-phenethyl-4-piperidine; N-phenyl-1-(2-phenylethyl)piperidin-4-amine; 1-phenethyl-N-phenylpiperidin-4-amine; despropionylfentanyl; 4-Anilino-N-phenethyl-4-piperidine (ANPP) (+2) DEA Controlled Substance List: Schedule II OPSS entry
4-bromo-2,5-dimethoxyphenethylamine alpha-desmethyl DOB; Nexus; 2C-B; 2-(4-bromo-2,5-dimethoxyphenyl)ethylamine; 4-bromo-2,5-dimethoxyphenethylamine DEA Controlled Substance List: Schedule I OPSS entry
4-fluoro-N-methylcathinone 1-(4-fluorophenyl)-2-(methylamino)propan-1-one); flephedrone; 2-FMC; 4-FMC; 4-Fluoro-N-methylcathinone (4-FMC) DEA Controlled Substance List: Schedule I OPSS entry
4-fluoroisobutyryl fentanyl p-fluoroisobutyrfentanyl; N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; para-fluoroisobutyryl fentanyl; P-FIBF DEA Controlled Substance List: Schedule I OPSS entry
4-fluoromethylphenidate (±)-threo-4-fluoromethylphenidate; 4-FMPH; 4F-MPH Unapproved Drug NIH NCATS Inxight Drugs entry: 4-fluoromethylphenidate
4-hydroxytestosterone 4,17beta-dihydroxy-androst-4-en-3-one; 4,17β-dihydroxyandrost-4-en-3-one; 4,17beta-dihydroxyandrost-4-en-3-one; 4-hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3- one); 4,17β-dihydroxy-androst-4-en-3-one DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
4-MEAP 4-methyl-alpha-ethylaminopentiophenone; 4-methyl-α-ethylaminopentiophenone; 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one; 4-methyl-alpha-ethylaminopentiophenone (4-MEAP) DEA Controlled Substance List: Schedule I OPSS entry
4-MePPP 4-methyl-alphapyrrolidinopropiophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one); 4-methyl-alpha-pyrrolidinopropiophenone; 4-methyl-α-pyrrolidinopropiophenone; 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) DEA Controlled Substance List: Schedule I OPSS entry
4-methoxyamphetamine 4-methoxy-α-methylphenethylamine; PMA; p-methoxyamphetamine; 1-(4-methoxyphenyl)propan-2-amine; paramethoxyamphetamine DEA Controlled Substance List: Schedule I OPSS entry
4-methyl-N-ethylcathinone 4-MEC; 2-(ethylamino)-1-(4-methylphenyl)-1-propanone; 4-EMC; EMC; 4-ethylmethcathinone (+2) DEA Controlled Substance List: Schedule I OPSS entry
4-methylaminorex, cis-(+/-)- U4Euh; 4-methylaminorex (cis isomer); (±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine; (±)cis-4-methylaminorex; McN-422 DEA Controlled Substance List: Schedule I OPSS entry
4-methylamphetamine 4-MA; p-methylamphetamine; p-methylamfetamine Unapproved Drug; DoDI 1010.16 NIH NCATS Inxight Drugs entry: 4-methylamphetamine
4-methylbuphedrone 4-MeMABP; 4-MeBP DEA Controlled Substance List: Schedule I OPSS entry
4-OH-DiPT 4-hydroxy-N,N-diisopropyltryptamine Other reason DoDI 1010.04 Problematic Substance Use by DoD Personnel
4F-MDMB-BINACA methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) DEA Controlled Substance List: Schedule I OPSS entry
4F-MDMB-BUTICA 4fluoro-MDMB-BUTICA; methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate DEA Controlled Substance List: Schedule I OPSS entry
4′-methyl acetyl fentanyl N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide DEA Controlled Substance List: Schedule I OPSS entry
5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol CP-47,497 DEA Controlled Substance List: Schedule I OPSS entry
5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol CP-47,497 C8-homolog; cannabicyclohexanol DEA Controlled Substance List: Schedule I OPSS entry
5-alpha-hydroxy-laxogenin Biobras 16; BB-16; spirostan-6-one, 3,5-dihydroxy-, (3b,5a,25R)-; 25-R-spirostan-5a-diol-6-one-3-one; 25R,5α-spirostan-3β,5-diol-6-one (+12) FDA Warning Letter FDA Warning Letter: Does not meet the definition of a dietary ingredient
5-androstenedione 5-androsten-3,17-dione; androst-5-en-3,17-dione; androst-5-ene-3,17-dione DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
5-fluoro-PB-22 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester; 5F-PB-22; quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate DEA Controlled Substance List: Schedule I OPSS entry
5-fluoro-UR-144 [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone; XLR-11; XLR11 DEA Controlled Substance List: Schedule I OPSS entry
5-MeO-AMT 5-methoxy-alpha-methyltryptamine Other reason DoDI 1010.04 Problematic Substance Use by DoD Personnel
5-MeO-DET 5-methoxy-N,N-diethyltryptamine Other reason DoDI 1010.04 Problematic Substance Use by DoD Personnel
5-MeO-DIPT Foxy methoxy; FOXY; 5-methoxy-N,N-dipropyltryptamine; 5-MeO-DPT; 5-methoxy-N,N-diisopropyltryptamine DEA Controlled Substance List: Schedule I OPSS entry
5-MeO-DMT methylbufotenine; 5-methoxy-N,N-dimethyltryptamine; 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 4-methoxy-N,N-dimethyltryptamine; 4-MeO-DMT (+2) DEA Controlled Substance List: Schedule I OPSS entry
5-MeO-MiPT 5-methoxy-N-methyl-N-isopropyltryptamine Other reason DoDI 1010.04 Problematic Substance Use by DoD Personnel
5-N,6-N-bis(2-fluorophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine BAM15; 5-N,6-N-bis(2- fluorophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine-5,6-diamine WADA S4: Hormone and Metabolic Modulators OPSS entry
5alpha-androstan-3,6,17-trione 5alpha-androstane-3,6,17-trione; 5α-androstane-3,6,17-trione; 5α-androstan-3,6,17-trione DEA Controlled Substance List: Schedule III OPSS entry
5F-AB-PINACA 5-fluoro-AB-PINACA; N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
5F-ADB 5F-EMB-PINACA; methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate; 5F-MDMB-PINACA; 5-fluoro-ADB; 5F-AEB DEA Controlled Substance List: Schedule I OPSS entry
5F-AMB methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate; 5-fluoro-AMB; 5-fluoro-AMP; 2-(1-(5-Fluoropentyl)-1H-indazole-3-ylcarbonylamino)-3-methylbutanoic acid methyl ester DEA Controlled Substance List: Schedule I OPSS entry
5F-APINACA N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide; 5F-AKB48 DEA Controlled Substance List: Schedule I OPSS entry
5F-CUMYL-P7AICA 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
5F-CUMYL-PINACA 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide; SGT-25 DEA Controlled Substance List: Schedule I OPSS entry
5F-EDMB-PICA 5fluoro-EDMB-PICA; ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate; ethyl 2-[[1-(5-fluorophentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate DEA Controlled Substance List: Schedule I OPSS entry
5F-EDMB-PINACA ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate DEA Controlled Substance List: Schedule I OPSS entry
5F-MDMB-PICA 5-fluoro-EMB-PICA; 5F-MDMB-2201; 5FMDMB-PICA; 5F-EMB-PICA; methyl 2-(1-(5-fluoropentyl)-1Hindole-3-carboxamido)-3,3-dimethylbutanoate (+1) DEA Controlled Substance List: Schedule I OPSS entry
6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[F][1,2,4]triazolo[4,3-A][1,4]diazepine clonazolam DEA Controlled Substance List: Schedule I OPSS entry
6-bromo-androsta-1,4-diene-3,17-dione 6-bromo boldione; 6-bromoandrosta-1,4-diene-3,17-dione; 6-bromo-androstan-1,4-diene-3,17-dione DEA Controlled Substance List: Schedule III; WADA S4: Hormone and Metabolic Modulators OPSS entry
6-bromo-androstan-3,17-dione DEA Controlled Substance List: Schedule III OPSS entry
6-monoacetylmorphine 6-MAM DoDI 1010.16 OPSS entry
6alpha-methyl-androst-4-ene-3,17-dione 6α-methylandrostenedione; 6alpha-methylandrostenedione; 6α-methyl-androst-4-ene-3,17-dione; 6α-methyl-androst-4-en-3,17-dione DEA Controlled Substance List: Schedule III OPSS entry
7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro- 2H-benzo[E][1,4]diazepin-2-one diclazepam DEA Controlled Substance List: Schedule I OPSS entry
7-isopropoxyisoflavone 7-isopropoxy-3-phenyl-4H-chromen-4-one; Ipriflavone; Osten Unapproved Drug NIH NCATS Inxight Drugs entry: Ipriflavone
7-keto DHEA 7-keto-dehydroepiandrosterone; 3β-hydroxyandrost-5-ene-7,17-dione; 7-keto-DHEA; 7-oxodehydroepiandrosterone; 7-oxo-DHEA (+2) WADA S1: Anabolic Agents; Military policy DoDI 6130.06 Use of Dietary Supplements in the DoD
7alpha-hydroxy-DHEA 7α-hydroxy-DHEA (C.S.); 7-hydroxy-DHEA; 7-hydroxydehydroepiandrosterone; 7a-hydroxy-dehydroepiandrosterone; 7alpha-hydroxydehydroepiandrosterone (+7) WADA S1: Anabolic Agents OPSS entry
7beta-hydroxy-DHEA 7β-hydroxy-DHEA; 7b-hydroxydehydroepiandrosterone WADA S1: Anabolic Agents OPSS entry
8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[F][1,2,4]trazolo[4,3-A][1,4]diazepine flubromazolam DEA Controlled Substance List: Schedule I OPSS entry
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[F][1,2,4]triazolo[4,3-A][1,4]diazepine flualprazolam DEA Controlled Substance List: Schedule I OPSS entry
9-hydroxyfluorene fluorenol; hydrafinil; fluoren-9-ol; 9-fluorenol; 9 fluorenol WADA S6: Stimulants OPSS entry
[3,2-c]-furazan-5alpha-androstan-17beta-ol [3,2-c]-furazan-5α-androstan-17β-ol DEA Controlled Substance List: Schedule III OPSS entry
[3,2-c]pyrazole-androst-4-en-17beta-ol [3,2-c]pyrazole-androst-4-en-17β-ol DEA Controlled Substance List: Schedule III OPSS entry
AB-CHMINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
AB-FUBINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
AB-PINACA N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
AC-262536 AC-262,536; 4-(3-endo-hydroxy-8-azabicyclo(3.2.1)oct-8-yl)naphthalene-1-carbonitrile WADA S1: Anabolic Agents; FDA Statement Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
Acacia rigidula Chaparro prieto; Acaciopsis rigidula; blackbrush acacia; Acacia rigidula extract (98%); Vachellia rigidula (+2) FDA Statement FDA: Acacia rigidula in Dietary Supplements
ACE-031 Ramatercept WADA S4: Hormone and Metabolic Modulators OPSS entry
acetazolamide acetazolamide sodium WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Acetazolamide
acetorphine 7alpha-etorphine 3-acetate DEA Controlled Substance List: Schedule I OPSS entry
acetyl fentanyl N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide; acetylfentanyl DEA Controlled Substance List: Schedule I OPSS entry
acetyl-alpha-methylfentanyl acetyl-α-methylfentanyl; alphamethylacetylfentanyl; N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide DEA Controlled Substance List: Schedule I OPSS entry
acetyldihydrocodeine dihydrothebacone; dihydrocodeine 6-acetate DEA Controlled Substance List: Schedule I OPSS entry
acetylmethadol acemethadone; methadyl acetate DEA Controlled Substance List: Schedule I OPSS entry
acetylpsilocin O-acetylpsilocin ; 4-AcO-DMT; psilacetin; 4-acetoxy-N,N-dimethyltryptamine; 4-acetoxy-DMT Military policy DoDI 1010.04 Problematic Substance Use by DoD Personnel and DoDI 6130.06 Use of Dietary Supplements in the DoD
Aconitum aconite root; queen of poisons; mousebane; leopard's bane; wolfsbane (+12) Other reason NIH NCATS Inxight Drugs entry: Aconitine
ACP-105 2-chloro-4-[(1R,5R)-3-hydroxy-3-methyl-8-azabicyclo[3.2.1] octan-8-yl]-3-methylbenzonitrile; 2-chloro-4-[(1R,5S)-3-hydroxy-3-methyl-8-azabicyclo[3.2.1]octan-8-yl]-3-methylbenzonitrile; Acadibol WADA S1: Anabolic Agents; FDA Statement Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
acryl fentanyl acryloylfentanyl; acrylfentanyl; N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide DEA Controlled Substance List: Schedule I OPSS entry
adamantoyl AB-001; 1-pentyl-3-(1-adamantoyle)indole DoDI 1010.16 OPSS entry
ADB-4en-PINACA N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
ADB-BUTINACA N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
ADB-FUBINACA N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
ADB-PINACA N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
adrafinil benzhydrylsulfinylacetohydroxamic acid; 2-((diphenylmethyl)sulfinyl)acetohydroxamsaeure; Noofon; 2-((diphenylmethyl)sulfinyl)acetohydroxamic acid; acetohydroxamic acid, 2-((diphenylmethyl)sulfinyl)- (+7) FDA Statement FDA Statement
adrenosterone 11-keto-androstenedione; androst-4-ene-3,11,17-trione; 11-OXO; andrenosterone; 4-androstene-3,11,17-trione (+6) WADA S1: Anabolic Agents OPSS entry
aegeline aegelin; N-2-hydroxy-2(4-methoxyphenyl) ethyl-3-phenyl-2-propenamide; egeline FDA Warning Letter FDA warning letter: New dietary ingredient lacking evidence for safe use; associated adverse events reported
AH-7921 3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide DEA Controlled Substance List: Schedule I OPSS entry
AICAR 5-amino-1-β-D-ribofuranosylimidazole-4-carboxamide monophosphate; 5-amino-4-imidazolecarboxamide ribofuranoside 5'-monophosphate; AICA ribonucleotide; NSC 283955; AICA ribonucleotide, (D-ribofuranosyl)-isomer (+11) WADA S4: Hormone and Metabolic Modulators OPSS entry
alexamorelin WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
alfaxalone 5alpha-pregnan-3alpha-ol-11,20-dione; Alfaxan DEA Controlled Substance List: Schedule IV OPSS entry
alfentanil alfentanyl; Alfenta; N-(1-(2-(4-ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide DEA Controlled Substance List: Schedule II OPSS entry
allylprodine alperidine; 4-piperidinol, 1-methyl-4-phenyl-3-(2-propenyl)-, propanoate (ester) DEA Controlled Substance List: Schedule I OPSS entry
alpha'-methyl butyryl fentanyl 2-methyl-N-(1­phenethylpiperidin-4-yl)-N-phenylbutanamide; α'-methyl butyryl fentanyl DEA Controlled Substance List: Schedule I OPSS entry
alpha-ethyltryptamine ET; etryptamine; Trip; α-ethyltryptamine; Monase (+5) DEA Controlled Substance List: Schedule I OPSS entry
alpha-methylfentanyl N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; α-methylfentanyl; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine DEA Controlled Substance List: Schedule I OPSS entry
alpha-methylthiofentanyl N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide; α-methylthiofentanyl DEA Controlled Substance List: Schedule I OPSS entry
alpha-methyltryptamine 3-(2-aminopropyl)indole; AMT; N-methyltryptamine; Indopan; α-methyltryptamine DEA Controlled Substance List: Schedule I OPSS entry
alpha-PHP alpha-pyrrolidinohexiophenone; α-PHP; alpha-pyrrolidinohexanophenone; 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one DEA Controlled Substance List: Schedule I OPSS entry
alpha-PiHP 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one; α-PiHP DEA Controlled Substance List: Schedule I OPSS entry
alpha-pyrrolidinobutiophenone alpha-PBP; α-PBP; 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one DEA Controlled Substance List: Schedule I OPSS entry
alpha-pyrrolidinopentiophenone flakka; α-pyrrolidinovalerophenone; 1-phenyl-2- (pyrrolidin-1-yl)pentan-1-one; 1-phenyl-2-(piperidin-1-yl)butan-1-one); α-PVP (+4) DEA Controlled Substance List: Schedule I OPSS entry
alphacetylmethadol alphacemethadone; alpha-3-acetoxy-6-dimethylamino-4,4-diphenylheptane; alphacetylmathadol DEA Controlled Substance List: Schedule I OPSS entry
alphameprodine 3alpha-ethyl-1-methyl-4-phenyl-4alpha-piperidyl propionat; 3α-ethyl-1-methyl-4-phenyl-4α-piperidyl propionat DEA Controlled Substance List: Schedule I OPSS entry
alphamethadol alpha-methadol DEA Controlled Substance List: Schedule I OPSS entry
alphaprodine prodine; 1,3-dimethyl-4-phenyl-4-propionoxypiperidine; Nisentil DEA Controlled Substance List: Schedule II OPSS entry
alprazolam α-hydroxy-alprazolam; Xanax DEA Controlled Substance List: Schedule IV OPSS entry
Amanita muscaria fly agaric mushroom; ibotenic acid; muscarine; muscimol Military policy DoDI 1010.04 Problematic Substance Use by DoD Personnel and DoDI 6130.06 Use of Dietary Supplements in the DoD
AMB-FUBINACA methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate; FUB-AMB; MMB-FUBINACA DEA Controlled Substance List: Schedule I OPSS entry
amfetaminil amphetaminil; AN-1; N-cyanobenzylamphetamine Unapproved Drug; DoDI 1010.16 NIH NCATS Inxight Drugs entry: Amfetaminil
amiloride Midamor WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Amiloride
amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) DEA Controlled Substance List: Schedule I OPSS entry
aminoglutethimide Cytadren; 3-(4-Aminophenyl)-3-ethylpiperidine-2,6-dione WADA S4: Hormone and Metabolic Modulators OPSS entry
aminorex 4,5-dihydro-5-phenly-2-oxazolamine; aminoxaphen; 2-amino-5-phenyl-2-oxazoline; Apiquel DEA Controlled Substance List: Schedule I OPSS entry
amobarbital Amobarbital & noncontrolled active ingred.; isoamylethylbarbituric acid; 5-ethyl-5-isoamylbarbituric acid; Amytal DEA Controlled Substance List: Schedule II; DEA Controlled Substance List: Schedule III OPSS entry
amphetamine 1-methyl-2-phenylethylamine; Obetrol; desoxynorephedrine; alpha-methylphenethylamine; Dexedrine (+4) DEA Controlled Substance List: Schedule II OPSS entry
anamorelin RC-1291; 3-piperidinecarboxylic acid, 1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-, trimethylhydrazide, (3R)- WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
anastrozole Arimidex; 2-[3-(2-Vyanopropan-2-yl)-5-(1,2,4-triazol-1- ylmethyl)phenyl]-2-methylpropanenitrile WADA S4: Hormone and Metabolic Modulators; Prescription drug NIH NCATS Inxight Drugs entry: Anastrozole
andarine acetamidoxolutamide; (2S)-3-(4-acetamidophenoxy)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide; propanamide, 3-(4-(acetylamino)phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-, (2S)-; 3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethylphenyl)propionamide; SARM S-4 (+9) WADA S1: Anabolic Agents; FDA Statement NIH NCATS Inxight Drugs entry: Andarine
androsta-3,5-diene-7,17-dione 3,5-androstadiene-7,17-dione; androst-3,5-diene-7,17-dione; androst-3,5-dien-7,17-dione; arimistane; 3-deoxy-7-oxo-DHEA (+1) WADA S4: Hormone and Metabolic Modulators OPSS entry
androstadienone delta4,16-androstadien-3-one; Δ4,16-androstadien-3-one; androsta-4,16-dien-3-one; 4,16-androstadien-3-one WADA S1: Anabolic Agents OPSS entry
androstanediol 3α,17β-dihydroxy-5α-androstane; 3alpha-androstanediol; 3alpha,17beta-dihydroxy-5alpha-androstane; 5-α-androstan-3-α,17-β-diol; 3α-androstanediol (+3) DEA Controlled Substance List: Schedule III OPSS entry
androstanedione 5α-androstan-3,17-dione; 5α-androstane-3,17-dione; 5alpha-androstane-3,17-dione; 5alpha-androstan-3,17-dione DEA Controlled Substance List: Schedule III OPSS entry
androstanolone dihydrotestosterone; 5α-dihydrotestosterone; DHT; 17beta-hydroxy-5alpha-androstan-3-one; 5α-DHT (+9) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
androstatrienedione ATD; 1,4,6-androstatriene-3,17-dione; 3,17-keto-etiocholetriene; androsta 1,4,6 triene 3,17 dione; androst-1,4,6-triene-3,17-dione (+2) WADA S4: Hormone and Metabolic Modulators OPSS entry
androstenediol 5-androstene-3β-17β-diol; 3β,17β-dihydroxy-androst-5-ene; 3beta,17beta-dihydroxy-androst-5-ene; androst-5-ene-3,17-diol; 5-androstenediol (+2) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
androstenedione Δ4-androstenedione; 17-ketotestosterone; 4-androstene-3,17-dione; Adione; 4-androstenedione (+2) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
androsterone 3alpha-hydroxyetioallocholan-17-one; 5alpha-androsterone; 5α-androsterone; 3-epihydroxyetiollocholan-17-one; 5alpha-androstane-3alpha-ol-17-one (+6) WADA S1: Anabolic Agents OPSS entry
anileridine Leritine; Alidine; Nipecotan; Adopol; ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate (+1) DEA Controlled Substance List: Schedule II OPSS entry
aniracetam 1-anisoyl-2-pyrrolidinone; 1-(4-methoxybenzoyl)-2-pyrrolidinone; Draganon; 1-P-anisoyl-2-pyrrolidinone; Sarpul FDA Statement FDA Statement
APINACA N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide; AKB48 DEA Controlled Substance List: Schedule I OPSS entry
apitegromab WADA S4: Hormone and Metabolic Modulators OPSS entry
aprobarbital Alurate DEA Controlled Substance List: Schedule III OPSS entry
Areca catechu nut areca nut; betel nut; Areca catechu extract; arecoline Military policy DoDI 1010.04 Problematic Substance Use by DoD Personnel and DoDI 6130.06 Use of Dietary Supplements in the DoD
arformoterol formoterol R,R-form WADA S3: Beta-2 Agonists; Prescription drug NIH NCATS Inxight Drugs entry: Arformoterol
asialo EPO asialo erythropoietin; asialo-erythropoietin; ASIALO-EPO WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
barbital Plexonal; barbitone; Veronal; 5,5-diethylbarbituric acid DEA Controlled Substance List: Schedule IV OPSS entry
barbituric acid Malonylurea; barbituric acid derivative; 6-hydroxyuracil; barbiturates not specifically listed DEA Controlled Substance List: Schedule III OPSS entry
bazedoxifene WAY 140424; TSE-424; Bazedoxifeno; bazedoxifene acetate; WAY140424 (+6) WADA S4: Hormone and Metabolic Modulators; Prescription drug NIH NCATS Inxight Drugs entry: Bazedoxifene
bendroflumethiazide Naturetin; bendrofluazide; Aprinox WADA S5: Diuretics and Masking Agents OPSS entry
benzethidine ethyl 1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylate DEA Controlled Substance List: Schedule I OPSS entry
benzimidazole 1,3-benzodiazole; 1H-benzimidazole DoDI 1010.16 OPSS entry
benzoylecgonine 3-(benzoyloxy)-8-methyl-8-azabicyclo(3.2.1)octane-2-carboxylic acid; ecgonine benzoate DoDI 1010.16 OPSS entry
benzphetamine Didrex; benzfetamine; (R,S)-N-benzyl-alpha,N-dimethylphenethylamin; d-benzphetamine; Inapetyl DEA Controlled Substance List: Schedule III OPSS entry
benzylmorphine 3-benzyloxy-4,5alpha-epoxy-17-methyl-7-morphinen-6alpha-ol; O3-benzylmorphine DEA Controlled Substance List: Schedule I OPSS entry
beta'-phenyl fentanyl β′-phenyl fentanyl; beta'-phenyl fentanyl; N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; 3-phenylpropanoyl fentanyl DEA Controlled Substance List: Schedule I OPSS entry
beta-hydroxy-3-methylfentanyl N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide DEA Controlled Substance List: Schedule I OPSS entry
beta-hydroxyfentanyl N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide DEA Controlled Substance List: Schedule I OPSS entry
beta-hydroxythiofentanyl N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide; N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide DEA Controlled Substance List: Schedule I OPSS entry
beta-methyl fentanyl β-methyl fentanyl ; N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide DEA Controlled Substance List: Schedule I OPSS entry
betacetylmethadol (3S,6R)-3-acetoxy-6-dimethylamino-4,4-diphenylheptane; beta-1-ethyl-4-dimethylamino-2,2-diphenylpentyl acetat; betacemethadon; beta-3-acetoxy-6-dimethylamino-4,4-diphenylheptane DEA Controlled Substance List: Schedule I OPSS entry
betameprodine NU-1932 DEA Controlled Substance List: Schedule I OPSS entry
betamethadol DEA Controlled Substance List: Schedule I OPSS entry
betaprodine beta-1,3-dimethyl-4-phenyl-4-propionyloxypiperidine; beta-prodine; [(3R,4R)-1,3-dimethyl-4-phenylpiperidin-4-yl] propanoate DEA Controlled Substance List: Schedule I OPSS entry
bezitramide Burgodin DEA Controlled Substance List: Schedule II OPSS entry
bimagrumab human anti-ACTRIIB monoclonal antibody WADA S4: Hormone and Metabolic Modulators OPSS entry
bismuth nitrate bismuth(III) nitrate pentahydrate; bismuth trinitrate pentahydrate; nitric acid, bismuth(3+) salt; bismuth trinitrate; bismuth(III) nitrate OTC drug NIH NCATS Inxight Drugs entry: Bismuth nitrate
BMPEA beta-phenylpropylamine; B-Methylphenethylamine; ß-MePEA; 1-propanamine, 2-phenyl-; R-beta methylphenylethylamine (+23) FDA Statement FDA: BMPEA in Dietary Supplements
BMS-564929 benzonitrile, 2-chloro-3-methyl-4-((7R,7AS)-tetrahydro-7-hydroxy-1,3-dioxo-1H-pyrrolo(1,2-C)imidazol-2(3H)-yl)-; BMS-564,929 WADA S1: Anabolic Agents; FDA Statement Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
bolasterone 7alpha,17alpha-dimethyltestosterone; 7α,17α-dimethyl-17β-hydroxyandrost-4-en-3-one; 7alpha,17alpha-dimethyl-17betahydroxyandrost-4-en-3-one; 7α,17α-dimethyltestosterone DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
boldenone 1,4-androstadiene-3-one-17beta-ol; Parenabol; Equigan; Ganabol; 1,4-androstadiene-17-beta-ol-3-one (+11) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
boldione 1,4-AD; androsta-1,4-diene-3,17-dione; androstadienedione DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
BPC-157 PL-14736; Bepecin; body protection compound WADA S0: Non-approved Substances OPSS entry
bremelanotide PT-141 Prescription drug NIH NCATS Inxight Drugs: Bremelanotide
brexanolone allopregnan-3alpha-ol-20-one; allopregnanolone; 3α-hydroxy-5α-pregnan-20-one; allotetrahydroprogesterone DEA Controlled Substance List: Schedule IV OPSS entry
brivaracetam UCB-34714; BRV; Briviact; (2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide DEA Controlled Substance List: Schedule V OPSS entry
brolamfetamine 4-bromo-2,5-DMA; 4-bromo-2,5-dimethoxy-amphetamine; 4-bromo-2,5-dimethoxy-α-methylphenethylamine; 4-bromo-DMA DEA Controlled Substance List: Schedule I OPSS entry
bromazepam 7-bromo-5-(2-pyridyl)-3H-1,4-benzodiazepin-2(1H)-one; Lexotanil; Lexatin; Durazanil; Compedium (+1) DEA Controlled Substance List: Schedule IV OPSS entry
brorphine 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one; 1-[1-[1-(4-bromophenyl)ethyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one DEA Controlled Substance List: Schedule I OPSS entry
bufotenine 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; mappine; 3-(β-Dimethylaminoethyl)-5-hydroxyindole; 5-hydroxy-N,N-dimethyltryptamine DEA Controlled Substance List: Schedule I OPSS entry
bumetanide Bumex WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Bumetanide
buprenorphine Buprenex; Temgesic; Subutex; Suboxone DEA Controlled Substance List: Schedule III OPSS entry
buserelin tiloryth WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
butabarbital Butisol; secbutabarbital; Butibel DEA Controlled Substance List: Schedule III OPSS entry
butalbital Fiorinal; butalbital with aspirin DEA Controlled Substance List: Schedule III OPSS entry
butobarbital Soneryl; butethal DEA Controlled Substance List: Schedule III OPSS entry
butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1- amine); 1H-benzimidazole-1-ethanamine, 2-((4-butoxyphenyl)methyl)-N,N-diethyl-5-nitro-; 2-[(4-butoxyphenyl)methyl]-N,N-diethyl-5-nitro-1H-benzimidazole-1-ethanamine; 2-[2-[(4-butoxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamine DEA Controlled Substance List: Schedule I OPSS entry
butorphanol (-)-17-(cyclobutylmethyl)morphinan-3,14-diol; Stadol; Torbugesic; Torbutrol; Stadol NS (+1) DEA Controlled Substance List: Schedule IV OPSS entry
butylone MDDMC; bk-MDDMA; N,N-dimethyl-3,4-methylenedioxycathinone; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one); 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (+2) DEA Controlled Substance List: Schedule I OPSS entry
butyryl fentanyl N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide; N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide DEA Controlled Substance List: Schedule I OPSS entry
calusterone Mesosarb; 7β,17α-dimethyltestosterone; 7beta,17alpha-dimethyl-17betahydroxyandrost-4-en-3-one; 7β,17α-dimethyl-17β-hydroxyandrost-4-en-3-one DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
camazepam Limpidon; Paxor; Albego DEA Controlled Substance List: Schedule IV OPSS entry
cannabidiol CBD; Epidiolex; 1,3-benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-; delta1(2)-trans-cannabidiol; trans-cannabidiol (+3) Military policy Hemp and DoD policy
cannabigerol cannabigerol (CBG); Cannabis Extract 5% CBG; CBG DoDI 1010.16 OPSS entry
cannabinol 6,6,9-trimethyl-3-pentyl-benzo[c]chromen-1-ol; CBN DoDI 1010.16 OPSS entry
cannabis Cannabis sativa L.; Cannabis sativa DEA Controlled Substance List: Schedule I OPSS entry
canrenone Aldadiene WADA S5: Diuretics and Masking Agents OPSS entry
capromorelin CP-424,391 WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
carbamylated EPO cEPO WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
carbazole dibenzopyrrole; 9h-carbazole DoDI 1010.16 OPSS entry
carfentanil Wildnil DEA Controlled Substance List: Schedule III OPSS entry
carisoprodol Soma DEA Controlled Substance List: Schedule IV OPSS entry
Catha edulis khat; Abyssinian tea; Graba Military policy DoDI 1010.04 Problematic Substance Use by DoD Personnel and DoDI 6130.06 Use of Dietary Supplements in the DoD
cathine d-norpseudoephedrine; Fasupond; norpseudoephedrine; (+)-norpseudoephedrine; Exponcit (+1) DEA Controlled Substance List: Schedule IV OPSS entry
cathinone alpha-aminopropiophenone; 2-aminopropiophenone; 2-amino-1-phenyl-1-propanone; norephedrone DEA Controlled Substance List: Schedule I OPSS entry
cenobamate carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester); 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate DEA Controlled Substance List: Schedule V OPSS entry
cesium chloride cesium salt; CsCl; caesium chloride FDA Statement FDA: Cesium Chloride in Dietary Supplements
chloral betaine Beta Chlor DEA Controlled Substance List: Schedule IV OPSS entry
chloral hydrate Noctec DEA Controlled Substance List: Schedule IV OPSS entry
chlordiazepoxide Libritabs; Librium; SK-Lygen; Limbitrol DEA Controlled Substance List: Schedule IV OPSS entry
chlorhexadol Medodorm; Mecoral; Mechloral; Chloralodol DEA Controlled Substance List: Schedule III OPSS entry
chlorodehydromethylandrostenediol H-DROL; halodrol; 4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diol; 4-chloro-17a-methyl-androst-1,4-diene-3b,17b-diol; 4-chloro-17alpha-methyl-androst-1,4-diene-3beta,17beta-diol (+7) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
chloromethylandrostenediol Promagnon; 4-chloro-17alpha-methyl-androst-4-ene-3beta,17beta-diol; 4-chloro-17α-methyl-androst-4-ene-3β,17β-diol; 4-chloro-17-methyl-androst-4-ene-3,17-diol; methyl-clostediol (+2) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
chlorothiazide Diuril WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Chlorothiazide
chlorphentermine Desopimon; Apsedon; Pre-Sate; Lucofen DEA Controlled Substance List: Schedule III OPSS entry
chlorthalidone chlortalidone WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Chlorthalidone
clenbuterol Clen WADA S1: Anabolic Agents OPSS entry
clobazam Urbanyl; Urbadan DEA Controlled Substance List: Schedule IV OPSS entry
clobenzorex benzeneethanamine, N-((2-chlorophenyl)methyl)-α-methyl-, (S)-; (+)-N-(O-chlorobenzyl)-alpha-methylphenethylamine; benzeneethanamine, N-((2-chlorophenyl)methyl)-alpha-methyl-, (S)-; (+)-N-(O-chlorobenzyl)-α-methylphenethylamine Unapproved Drug; DoDI 1010.16 NIH NCATS Inxight Drugs entry: Clobenzorex
clomifene clomifen; clomifenum; Serophene; 2-(4-(2-chloro-1,2-diphenylethenyl)phenoxy)-N,N-diethylethanamine; Klostilbegit (+19) WADA S4: Hormone and Metabolic Modulators; Prescription drug NIH NCATS Inxight Drugs entry: Clomiphene
clonazepam klonopin; clonopin DEA Controlled Substance List: Schedule IV OPSS entry
clonitazene benzimidazole, 2-(p-chlorobenzyl)-1-(2-(diethylamino)ethyl)-5-nitro-; clobedolum; 2-(p-chlorobenzyl)-1-(2-diethylaminoethyl)-5-nitrobenzimidazole DEA Controlled Substance List: Schedule I OPSS entry
clorazepate Tranxene DEA Controlled Substance List: Schedule IV OPSS entry
clortermine Voranil DEA Controlled Substance List: Schedule III OPSS entry
clostebol clostebol acetate; 4-chlorotestosterone; Alfa-Trofodermin; 4-chloro-17beta-hydroxyandrost-4-en-3-one; 4-chloro-Δ4-androstene-3α-ol-17-one (+3) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
clotiazepam Trecalmo; Rize; Veratran; Clozan DEA Controlled Substance List: Schedule IV OPSS entry
cloxazolam Akton; Olcadil; Luballix; Sepazon DEA Controlled Substance List: Schedule IV OPSS entry
CNTO-530 WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
cobalt cobalt chloride WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
cocaine coca leaves; methyl benzoylecgonine; Crack DEA Controlled Substance List: Schedule II OPSS entry
cocaine metabolites DoDI 1010.16 OPSS entry
codeine morphine methyl ester; methyl morphine DEA Controlled Substance List: Schedule II OPSS entry
codeine methylbromide codeine bromomethylate; Eucodin; codeine methyl bromide DEA Controlled Substance List: Schedule I OPSS entry
codeine-N-oxide codeine N-oxide DEA Controlled Substance List: Schedule I OPSS entry
coluracetam N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro(2,3-B)quinolin-4-YL)-2-(2-oxopyrrolidin-1-YL)acetamide FDA Statement FDA Statement
conivaptan WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Conivaptan
corticorelin corticorelin acetate WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
CP-47,497 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol; 5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol; CP-47,497 C8 Homologue DEA Controlled Substance List: Schedule I OPSS entry
crotonyl fentanyl (E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide DEA Controlled Substance List: Schedule I OPSS entry
CUMYL-4CN-BINACA 4-cyano-CUMYL-BUTINACA; 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide; 4-CN-CUMYL BINACA; SGT-78; 4-CN-CUMYL-BUTINACA DEA Controlled Substance List: Schedule I OPSS entry
CUMYL-PEGACLONE 5-pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-B]indole-1-one DEA Controlled Substance List: Schedule I OPSS entry
cyanostane 2-cyano-17a-methyl-17b-hydroxy androst-3-one; 2-cyano-17a-methyl-17b-hydroxy-5a-androst-3-one; 2-cyano-17a-methyl-17b-hydroxy-androstan-3-one WADA S1: Anabolic Agents OPSS entry
cyclofenil Sexovid; NSC 86464; cyclophenyl; cyclophenil; Neoclym (+23) WADA S4: Hormone and Metabolic Modulators OPSS entry
cyclopentyl fentanyl N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide DEA Controlled Substance List: Schedule I OPSS entry
cyclopropyl fentanyl N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide DEA Controlled Substance List: Schedule I OPSS entry
cyprenorphine N-Cyclopropylmethyl-6,14-endoetheno-7alpha-(1-hydroxy-1-methylethyl)-6,7,8,14-tetrahydronororipavine; 6,14-endo-Ethenotetrahydrooripavine, 21-cyclopropyl-7alpha-(1-hydroxy-1-methylethyl)-; 2-(N-cyclopropylmethyl-4,5-epoxy-6-methoxy-6,14-endo-morphinan-7alpha-yl)-2-propanol DEA Controlled Substance List: Schedule I OPSS entry
cyproheptadine Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-; 1-Methyl-4-(dibenzo[a,e]cycloheptatrien-5-ylidene)piperidine; 4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine; Periactinol; Periactin (+2) Prescription drug NIH NCATS Inxight Drugs entry: Cyproheptadine
danazol [1,2]oxazolo[4',5':2,3]pregna-4-en-20-yn-17α-ol; Danocrine; Danol WADA S1: Anabolic Agents; Prescription drug NIH NCATS Inxight Drugs entry: Danazol
dapoxetine FDA Statement FDA: Public Notification
daprodustat GSK1278863 WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
darbepoetin alfa Aranesp; darbepoetin WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Darbepoetin alfa
daridorexant methanone, ((2S)-2-(6-chloro-7-methyl-1H-benzimidazol-2-yl)-2-methyl-1-pyrrolidinyl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)-; Nemorexant; Quviviq; [(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1-yl]-[5-methoxy-2-(triazol-2-yl)phenyl]methanone; [(2~{S})-2-(6-chloranyl-7-methyl-1~{H}-benzimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-methoxy-2-(1,2,3-triazol-2-yl)phenyl]methanone (+5) DEA Controlled Substance List: Schedule IV OPSS entry
dehydrochlormethyltestosterone dehydrochloromethyltestosterone; oral-turinabol; turinabol-oral; 4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one; oral turinabol (+4) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
dehydroepiandrosterone 5-androsten-3-beta-hydroxy-17-one; 3b-hydroxy-androst-5-ene-17-one; 3beta-hydroxy-androst-5-ene-17-one; trans-dehydroandrosterone; Prasterone, 3 alpha Isomer (+18) WADA S1: Anabolic Agents; Military policy DoDI 6130.06 Use of Dietary Supplements in the DoD
delorazepam chlordesmethyldiazepam; nordiclazepam DEA Controlled Substance List: Schedule IV OPSS entry
demelverine N-methyl-β,β′-diphenyldiethylamine; N-methyl-N-(2-phenylethyl)benzeneethanamine; N-methylbis(2-phenylethyl)amine; N-methyl-N-phenethyl-2-phenylethanamine; diphenethylamine, N-methyl- (+7) Military policy DoDI 6130.06 Use of Dietary Supplements in the DoD
des(1-3)IGF-1 WADA S2: Peptide Hormones, Growth Factors, etc.; DoDI 1010.16 OPSS entry
Desidustat ZYAN1 WADA S2: Peptide Hormones, Growth Factors, etc.; DoDI 1010.16 OPSS entry
deslorelin D-TRP-LHRH-PEA WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
desmopressin DDAVP; Stimate; Nocdurna WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Desmopressin
desomorphine 6-deoxy-7,8-dihydromorphine; dihydrodesoxymorphine-D; 4,5-epoxy-3-hydroxy-N-methylmorphinan; Permonid; crocodile (+3) DEA Controlled Substance List: Schedule I OPSS entry
desoxymethyltestosterone Pheraplex; 17α-methyl-5α-androst-2-en-17β-ol; 17α-methyl-5α-androst-3-en-17β-ol; madol; 17alpha-methyl-5alpha-androst-2-en-17beta-ol (+1) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
desoxytestosterone 5α-androst-2-en-17β-ol; 5α-androst-3-en-17β-ol WADA S1: Anabolic Agents; DoDI 1010.16 OPSS entry
dextromoramide Jetrium; Palfium; Narcolo DEA Controlled Substance List: Schedule I OPSS entry
dextropropoxyphene propoxyphene; Darvon; alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane; Darvocet; Propacet DEA Controlled Substance List: Schedule II; DEA Controlled Substance List: Schedule IV OPSS entry
diampromide N-[2-(methylphenethylamino)propyl]propionanilide; propionanilide, N-(2-(methylphenethylamino)propyl)- DEA Controlled Substance List: Schedule I OPSS entry
diazepam Valium; Diastat DEA Controlled Substance List: Schedule IV OPSS entry
dichloralphenazone dichloralantipyrine; Midrin DEA Controlled Substance List: Schedule IV OPSS entry
dienolone estra-4,9-dien-17b-ol-3-one; dienalone; 3-oxo-4,9-estradien-17β-ol; RU 3118; 17β-Hydroxy-estra-4,9-dien-3-one (+3) WADA S1: Anabolic Agents OPSS entry
diethylpropion diethylpropione; Danylen; amfepramon; amphepramone; Derfon (+14) DEA Controlled Substance List: Schedule IV OPSS entry
diethylthiambutene DEA Controlled Substance List: Schedule I OPSS entry
diethyltryptamine DET; MiPT; N,N-diethyltryptamine; N-methyl-N-isopropyltryptamine DEA Controlled Substance List: Schedule I OPSS entry
difenoxin Lyspafen; Motofen DEA Controlled Substance List: Schedule I OPSS entry
dihexa N-hexanoic-Tyr-Ile-(6) aminohexanoic amide; L-Isoleucinamide, N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-; PNB-0408 FDA Statement FDA: Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
dihydrocodeine Parzone; Didrate DEA Controlled Substance List: Schedule II OPSS entry
dihydroetorphine tetrahydro-7alpha-(1-hydroxy-1-methylbutyl)-6,14-endo-ethanooripavine; DHE; 7,8-dihydro-7alpha-(1-(R)-hydroxy-1-methylbutyl)-6,14-endo-ethanotetrahydrooripavine; 18,19-dihydroetorphine DEA Controlled Substance List: Schedule II OPSS entry
dihydromorphine 7,8 dihydromorphine; Paramorphan; 6-alpha-hydromorphol; hydromorphine; 7,8-dihydromorphine DEA Controlled Substance List: Schedule I OPSS entry
dimenoxadol Lokarin; 2-(dimethylamino)ethyl ethoxydiphenylacetate; dimenoxadole; 2-(dimethylamino)ethyl 2-ethoxy-2,2-diphenylacetate; Estocine DEA Controlled Substance List: Schedule I OPSS entry
dimepheptanol methadol; racemethadol DEA Controlled Substance List: Schedule I OPSS entry
dimethandrolone 7alpha,11beta-dimethyl-19-nortestosterone; 7α,11β-dimethyl-19-nortestosterone WADA S1: Anabolic Agents OPSS entry
dimethoxymethamphetamine 3,4-dimethoxymethamphetamine; DMMA DoDI 1010.16 OPSS entry
dimethylthiambutene dimethibutin; aminobutene; 3-dimethylamino-1,1-bis(2-thienyl)-1-butene; N,N,1-trimethyl-3,3-di-2-thienylallylamine; Ohton DEA Controlled Substance List: Schedule I OPSS entry
dimethyltrienolone 17β-Hydroxy-7α,17α-dimethyl-estra-4,9,11-trien-3-one; 17beta-hydroxy-7alpha,17alpha-dimethyl-estra-4,9,11-trien-3-one; RU-2420 WADA S1: Anabolic Agents; DoDI 1010.16 OPSS entry
dimethyltryptamine DMT; N,N-dimethyltryptamine DEA Controlled Substance List: Schedule I OPSS entry
dinitrophenol 2.4-dinitrophenol; Dinosan; Nitrophen; Mitcal; DNP (+6) WADA S0: Non-approved Substances OPSS entry
dioxaphetyl butyrate ethyl 4-morpholino-2,2-diphenylbutyrate; 4-morpholinebutanoic acid, alpha,alpha-diphenyl-, ethyl ester; Amidalgon; Spasmoxal DEA Controlled Substance List: Schedule I OPSS entry
diphenoxylate DEA Controlled Substance List: Schedule II OPSS entry
dipipanone phenylpiperone HCl; Wellconal; Dipipan; Diconal DEA Controlled Substance List: Schedule I OPSS entry
DiPT N,N-diisopropyltryptamine Other reason DoDI 1010.04 Problematic Substance Use by DoD Personnel
DMAA (1,3) 1,3-DMAA; dimethylpentylamine; Floradrene; 1,3-dimethylpentylamine; methylhexanamine (+12) FDA Statement FDA: DMAA in Dietary Supplements
DMAA (1,4) 5-methyl-2-hexylamine; 5-methylhexan-2-amine; 1,4 dimethylamylamine; 1,4-DMAA; DMPA (+2) FDA Warning Letter FDA Warning Letter
DMBA 1,3-DMBA; 1,3-dimethylbutanamine; 4-methyl-2-pentanamine; 4-amino-2-methylpentane citrate; 4-amino-2-pentanamine (+14) FDA Statement FDA: DMBA in Dietary Supplements
DMHA Vaporpac; 1,5-DMHA; 2-isooctyl amine; 2-aminoisoheptane HCl (DMHA); 6-methyl-2-heptylamine (+16) FDA Statement FDA: DMHA in Dietary Supplements
DOB 4-bromo-2,5-dimethoxyamphetamine; 4-bromo-DMA DEA Controlled Substance List: Schedule I OPSS entry
DOC 2,5-dimethoxy-4-chloroamphetamine DoDI 1010.16 OPSS entry
DOET 2,5-dimethoxy-4-ethylamphetamine; 2,5-dimethoxy-4-ethylamphet-amine DEA Controlled Substance List: Schedule I OPSS entry
DOI 2,5-dimethoxy-4-iodoamphetamine DoDI 1010.16 OPSS entry
DOM STP; 4-methyl-2,5-dimethoxy-α-methylphenethylamine; 2C-G; 4-methyl-2,5-dimethoxy-amphetamine; 2,5-Dimethoxy-3,4-dimethylphenethylamine (+1) DEA Controlled Substance List: Schedule I OPSS entry
domagrozumab PF-06252616 WADA S4: Hormone and Metabolic Modulators OPSS entry
dronabinol (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo [b,d]pyran-1-ol; (-)-delta-9-(trans)-tetrahydrocannabinol; Syndros; Marinol; (-)-delta-9-trans tetrahydrocannabinol DEA Controlled Substance List: Schedule II OPSS entry
drostanolone Masteron; Masterone; Drolban; 17beta-hydroxy-2alpha-methyl-5alphaandrostan-3-one; Masteril (+6) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
drotebanol oxymethebanol; Metabanyl DEA Controlled Substance List: Schedule I OPSS entry
ecgonine cocaine precursor DEA Controlled Substance List: Schedule II OPSS entry
ecgonine methyl ester EME; methylecgonine DoDI 1010.16 OPSS entry
elacestrant WADA S4: Hormone and Metabolic Modulators OPSS entry
eluxadoline VIBERZI; 5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid DEA Controlled Substance List: Schedule IV OPSS entry
embutramide Tributane DEA Controlled Substance List: Schedule III OPSS entry
Enarodustat JTZ-951 WADA S2: Peptide Hormones, Growth Factors, etc.; DoDI 1010.16 OPSS entry
enobosarm MK2866 acetic acid ester; GTx-024; GTx 024; Ostarine; S22 (+16) WADA S1: Anabolic Agents; FDA Statement Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
ephedra epitonin; Sida cordifolia Linn; Ephedra intermedia; heart-leaf sida; Pinellia ternata (+6) Other reason Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk
ephedrine alkaloids norephedrine; ephedrine; ephedra alkaloids; N-pseudoephedrine Other reason Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk
epi-dihydrotestosterone 5beta-DHT; 5beta-dihydrotestosterone; 17beta-hydroxyetiocholan-3-one; 17β-hydroxy-5β-androstan-3-one; etiocholan-17β-ol-3-on (+7) WADA S1: Anabolic Agents OPSS entry
epiandrosterone trans-androsterone; 3beta-hydroxy-5alpha-androstan-17-one; 3b-hydroxy-5a-androstan-17-one; epiandrosterone (from pine pollen); epiandrostenolone (+14) WADA S1: Anabolic Agents OPSS entry
epistane havoc; 2α,3α-Epithio-5α-androstan-17α-methyl-17β-ol; epitiostanol; 2,3-thioepoxy madol; epi plex (+7) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
epitalon FDA Statement FDA: Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
epitestosterone 17alpha-testosterone; 17alpha-hydroxyandrost-4-en-3-one; 17α-testosterone; cis-testosterone; isotestosterone (+5) WADA S1: Anabolic Agents OPSS entry
epitrenbolone α-trenbolone; 17alpha-hydroxytrenbolone; estra-4,9,11-trien-3-one, 17-hydroxy-, (17-alpha)-; 17alpha-trenbolone; 17α-trenbolone (+4) WADA S1: Anabolic Agents OPSS entry
epthiostane 17β-hydroxy-2α,3α-epithio-5α-androstane WADA S1: Anabolic Agents; DoDI 1010.16 OPSS entry
erythropoietin rEPO; epoetin alfa; epoetin epsilon; EPO; epoetin kappa (+10) WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Erythropoietin
erythropoietin Fc EPO-Fc WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
estazolam Eurodin; Domnamid; Nuctalon; ProSom DEA Controlled Substance List: Schedule IV OPSS entry
estra-4,9,11-triene-3,17-dione trenavar; trendione DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
ethacrynic acid etacrynic acid; sodium ethacrynate; ethacrinic acid WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Ethacrynic acid
ethchlorvynol Placidyl DEA Controlled Substance List: Schedule IV OPSS entry
ethinamate Valmid; Valamin DEA Controlled Substance List: Schedule IV OPSS entry
ethyl loflazepate Meilax; Ronlax; Victan; ethyl 7-chloro-2,3-dihydro-5-(2-fluorophenyl)-2-OXO-1H-1,4-benzodiazepine-3-carboxylate; CM 6912 DEA Controlled Substance List: Schedule IV OPSS entry
ethylestrenol 17alpha-ethyl-17beta-hydroxyestr-4-ene; 17α-ethyl-17β-hydroxyestr-4-ene; Orabolin; 19-norpregna-4-en-17α-ol; 19-norpregna-4-en-17ɑ-ol (+3) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
ethylmethylthiambutene DEA Controlled Substance List: Schedule I OPSS entry
ethylmorphine Dionin DEA Controlled Substance List: Schedule II OPSS entry
ethylone MDEC; 3,4-methylenedioxy-N-ethylcathinone; bk-MDEA; βk-MDEA; 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one DEA Controlled Substance List: Schedule I OPSS entry
ethylphenidate EPH; ethylphenidate, threo- DEA Controlled Substance List: Schedule I OPSS entry
etiocholanolone 3alpha-hydroxy-5beta-androstan-17-one; 5-isoandrosterone; 3α-hydroxy-5β-androstan-17-one WADA S1: Anabolic Agents; DoDI 1010.16 OPSS entry
etodesnitazene Etazone; benzimidazole, 1-(2-(diethylamino)ethyl)-2-(p-ethoxybenzyl)-; 1H-benzimidazole-1-ethanamine, 2-((4-ethoxyphenyl)methyl)-N,N-diethyl-; 2-(2-(4-ethoxybenzyl)-1Hbenzimadazol-1-yl)-N,N-diethylethan-1-amine; 2-((4-ethoxyphenyl)methyl)-N,N-diethyl-1H-benzimidazole-1-ethanamine (+4) DEA Controlled Substance List: Schedule I OPSS entry
etonitazene Chinese Dwarf; 1-(2-(diethylamino)ethyl)-2-(p-ethoxybenzyl)-5-nitrobenzimidazole; etonitazine DEA Controlled Substance List: Schedule I OPSS entry
etorphine hydrochloride M 99; etorphine HCl DEA Controlled Substance List: Schedule II OPSS entry
etoxeridine Wy-2039; Carbetidine; Atenos; isonipecotic acid, 1-(2-(2-hydroxyethoxy)ethyl)-4-phenyl-, ethyl ester; ethyl 1-[2-(2-hydroxyethoxy)ethyl]-4-phenylpiperidine-4-carboxylate DEA Controlled Substance List: Schedule I OPSS entry
eutylone 1-(1,3-benzodioxol-5-yl)-2(ethylamino)butan-1-one DEA Controlled Substance List: Schedule I OPSS entry
examorelin hexarelin WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
exemestane Aromasin; PNU-155971; 6-methylenandrosta-1,4-diene-3,17-dione; exemestano; FCE-24304 (+10) WADA S4: Hormone and Metabolic Modulators; Prescription drug NIH NCATS Inxight Drugs entry: Exemestane
ezogabine Potiga; N-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester DEA Controlled Substance List: Schedule V OPSS entry
fencamfamin Reactivan DEA Controlled Substance List: Schedule IV OPSS entry
fencamine Sicoclor; 1,3,7-trimethyl-8-[2-[methyl(1-phenylpropan-2-yl)amino]ethylamino]purine-2,6-dione; Altimina DoDI 1010.16 OPSS entry
fenethylline amfetyline; ethyltheophylline amphetamine; fenetylline; Captagon DEA Controlled Substance List: Schedule I OPSS entry
fenoterol (1RS)-1-(3,5-dihydroxyphenyl)-2-(((1RS)-2-(4-hydroxyphenyl)-1-methylethyl)amino)ethanol; 3,5-dihydroxy-alpha-(((P-hydroxy-alpha-methylphenethyl)amino)methyl)benzyl alcohol; 3,5-dihydroxy-α-(((P-hydroxy-α-methylphenethyl)amino)methyl)benzyl alcohol; 1,3-benzenediol, 5-(1-hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)ethyl)- WADA S3: Beta-2 Agonists OPSS entry
fenproporex Solvolip; Gacilin DEA Controlled Substance List: Schedule IV OPSS entry
fentanyl Actiq; Innovar; Duragesic; Oralet; Sublimaze DEA Controlled Substance List: Schedule II OPSS entry
fentanyl carbamate ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate DEA Controlled Substance List: Schedule I OPSS entry
fludiazepam DEA Controlled Substance List: Schedule IV OPSS entry
flunitazene 1H-benzimidazole-1-ethanamine, N,N-diethyl-2-((4-fluorophenyl)methyl)-5-nitro-; benzimidazole, 1-(2-(diethylamino)ethyl)-2-(p-fluorobenzyl)-5-nitro-; N,N-diethyl-2-((4-fluorophenyl)methyl)-5-nitro-1H-benzimidazole-1-ethanamine; N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine DEA Controlled Substance List: Schedule I OPSS entry
flunitrazepam Roipnol; Rohypnol; Narcozep; Darkene DEA Controlled Substance List: Schedule IV OPSS entry
fluoxymesterone Halotestin; Ora-Testryl; Stenox; 9-fluoro-17α-methyl-11β,17β-dihydroxyandrost-4-en-3-one; 9α-Fluoro-11β,17β-dihydroxy-17α-methylandrost-4-en-3-one (+3) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
flurazepam Dalmane DEA Controlled Substance List: Schedule IV OPSS entry
follistatin activin-binding protein; FST WADA S4: Hormone and Metabolic Modulators OPSS entry
fonturacetam phenylpiracetam; carphedon; Karfedon; Carphedone; 4-phenylpiracetam (+1) FDA Statement FDA Statement
formebolone 2-Formyl-17α-methyl-1,4-androsta-1,4-dien-11α,17β-diol-3- one; Esiclene; 2-formyl-17alpha-methyl-11alpha,17beta-dihydroxyandrost-1,4-dien-3-one; 2-formyl-17α-methyl-11α,17β-dihydroxyandrost-1,4-dien-3-one; Hubernol DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
formestane 4-hydroxy-delta(sub 4)-androstenedione; 4-hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5alpha-androstan-17beta-ol; BRN 1889793; 4-hydroxy-androst-4-ene-3,17-dione; 4-hydroxyandrost-4-ene-3,17-dione (+13) DEA Controlled Substance List: Schedule III; WADA S4: Hormone and Metabolic Modulators OPSS entry
formoterol eformoterol; Turbuhaler®; Oxis®; formamide, N-(2-hydroxy-5-(1-hydroxy-2-((2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)- WADA S3: Beta-2 Agonists; Prescription drug NIH NCATS Inxight Drugs entry: Formoterol
fospropofol Lusedra DEA Controlled Substance List: Schedule IV OPSS entry
FP-3 Pentobarbital & noncontrolled active ingred DEA Controlled Substance List: Schedule III OPSS entry
FUB-144 [1-[(4-Fluorophenyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone; FUB-UR-144; (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone; Methanone, [1-[(4-fluorophenyl)methyl]-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)-; (1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone DEA Controlled Substance List: Schedule I OPSS entry
FUB-APINACA AKB48 N-(4-FLUOROBENZYL); FUB-AKB48; N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamid DEA Controlled Substance List: Schedule I OPSS entry
fulvestrant ICI 182,780; Faslodex; ICI-182780; ICI 182780; ZM182780 (+4) WADA S4: Hormone and Metabolic Modulators; Prescription drug NIH NCATS Inxight Drugs entry: Fulvestrant
furanyl fentanyl N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
furazabol Frazalon; 17alpha-methyl-17beta­-hydroxyandrostano[2,3-c]-furazan; Miotolon; 17ɑ-methyl [1,2,5] oxadiazolo[3’,4’:2,3]-5ɑ-androstan-17ß-ol; Furuza (+5) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
furethidine 1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester; ethyl 4-phenyl-1-(2-tetrahydrofurfuryloxyethyl)piperidine-4-carboxylate DEA Controlled Substance List: Schedule I OPSS entry
furfenorex furfurylmethylamphetamine Unapproved Drug; DoDI 1010.16 NIH NCATS Inxight Drugs entry: Furfenorex
furosemide Lasix WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Furosemide
galantamine Razadyne ER; Razadyne; Galantamine HBr; Galantamine hydrobromide Prescription drug; FDA Warning Letter FDA Warning Letter
gamma hydroxybutyric acid Anetamin; 4-hydroxybutanoic acid; gamma-hydroxybutyric acid; GHB; 4-hydroxybutyrate (+6) DEA Controlled Substance List: Schedule I OPSS entry
gamma-butyrolactone gamma butyrolactone; GBL; 4-butyrolactone DEA Controlled Substance List: Schedule I OPSS entry
ganaxolone 1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethan-1-one; 1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-Hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone; 1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one; (3alpha,5alpha)-3-Hydroxy-3-methylpregnan-20-one (+3) DEA Controlled Substance List: Schedule V OPSS entry
gestrinone (17alpha)-13-ethyl-17-hydroxy-18,19-dinorpregna-4,9,11-trien-20-yn-3-one; dimetriose; (17α)-13-ethyl-17-hydroxy-18,19-dinorpregna-4,9,11-trien-20-yn-3-one; 13-Ethyl-17a-ethynyl-17b-hydroxygona-4,9,11-trien-3-one; 13β-Ethyl-17β-hydroxy-18,19-dinor-17α-pregna-4,9,11-trien- 20-yn-3-one (+3) WADA S1: Anabolic Agents OPSS entry
GHRP-1 GHRP1; growth hormone-releasing peptide 1 WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
GHRP-6 growth hormone-releasing peptide hexapeptide; hexapeptide-2; growth hormone-releasing peptide 6 WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
glutethimide Doriden; Dorimide DEA Controlled Substance List: Schedule II OPSS entry
gonadorelin gonadotropin-releasing hormone; LHRH; luteinizing hormone-releasing factor; gonadorelin decapeptide; GNRH WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
goralatide Seraspenide; Ac-SDKP WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
goserelin WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Goserelin
growth hormone-releasing peptide GHRP; GHRP-5; GHRP-3; GHRP-4; GH-releasing peptides WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
GSK2881078 SARM GSK2881078 WADA S1: Anabolic Agents; DoDI 1010.16 OPSS entry
GW-0742 2-(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methyl)thio)-2-methylphenoxy)acetic acid; GW610742; GW-0742X; GWδ 0742; GW0742 (+9) WADA S4: Hormone and Metabolic Modulators OPSS entry
GW-501516 Cardarine; GW501516; 2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]- 1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid; GSK-516; GW-1516 (+4) WADA S4: Hormone and Metabolic Modulators OPSS entry
halazepam Paxipam DEA Controlled Substance List: Schedule IV OPSS entry
haloxazolam Haloxazolamum; Somelin; 10-bromo-11b-(2-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo(3,2-d)(1,4)benzodiazepin-6(5H)-one DEA Controlled Substance List: Schedule IV OPSS entry
HCG hCG; chorionic gonadotrophin (CG); human chorionic gonadotropin; chorionic gonadotropin; chorionic gonadotrophin WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Chorionic gonadotropin
hemp hemp seed protein powder; organic hemp protein concentrate; hemp seed protein; organic hemp protein powder ; hemp seed (+5) Military policy 26 February 2020 Memorandum from the Office of Under Secretary of Defense
heroin diacetylmorphine; diamorphine hydrochloride; diamorphine DEA Controlled Substance List: Schedule I OPSS entry
hexadrone 6-chloro-androst-4-ene-3-one-17beta-ol; 6-chloro-androst-4-ene-3-one-17β-ol; 6-chloro-androst-4-en-17b-ol-3-one WADA S1: Anabolic Agents; FDA Warning Letter FDA Warning Letter
hexedrone alpha-methylamino-caprophenone; 2-(methylamino)-1-phenyl-1-hexanone; α-methylamino-caprophenone; 1-hexanone, 2-(methylamino)-1-phenyl- DoDI 1010.16 OPSS entry
HGH Nutropin AQ; human growth hormone; Genotonorm; Nutropin Depot; Accretropin (+22) WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Somatropin
higenamine 6,7-isoquinolinediol, 1,2,3,4-tetrahydro-1-((4-hydroxyphenyl)methyl)-, (+-)-; (R)-higenamine; (R,S)-norcoclaurine; (+-)-demethylcoclaurine; higenamine hydrochloride (+18) WADA S3: Beta-2 Agonists; FDA Warning Letter FDA Warning Letter
histrelin WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Histrelin
hordenine anhaline; p-hydroxy-N,N-dimethylphenethylamine; eremursine; ordenina; peyocactine (+8) FDA Warning Letter FDA warning letter
hydrochlorothiazide Microzide; HCTZ WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Hydrochlorothiazide
hydrocodone dihydrocodeinone DEA Controlled Substance List: Schedule II OPSS entry
hydromorphinol 14-hydroxydihydromorphine; 7,8-dihydro-14-hydroxymorphine; RAM-320; 6alpha-Oxymorphol DEA Controlled Substance List: Schedule I OPSS entry
hydromorphone Dilaudid; dihydromorphinone DEA Controlled Substance List: Schedule II OPSS entry
hydroxyamphetamine hydroxyamfetamine; parahydroxyamphetamine DoDI 1010.16 OPSS entry
hydroxypethidine Demidone; Oxydolantin; ethyl 4-(3-hydroxyphenyl)-1-methylpiperidine-4-carboxylate; Oxipethidine; Oxypetidin (+2) DEA Controlled Substance List: Schedule I OPSS entry
hydroxypropyl betadex hydroxypropyl-β-cyclodextrin; hydroxypropyl-B-cyclodextrin; HP-β-CD; hydroxypropyl beta cyclodextrin; beta-hydroxypropylcyclodextrin (+14) Unapproved Drug FDA Designated Orphan Drug
ibogaine 7-Ethyl-6,6β,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino [5,4-b] indole; Tabernanthe iboga DEA Controlled Substance List: Schedule I OPSS entry
IGF Mecasermin; Somatomedin C; recombinant human insulin-like growth factor-1; IGF-1; insulin-like growth factor 1 WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Mecasermin
indacaterol Onbrez; QAB-149 WADA S3: Beta-2 Agonists; Discontinued drug NIH NCATS Inxight Drugs entry: Indicaterol
indapamide Lozol WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Indapamide
indene 1H-indene DoDI 1010.16 OPSS entry
IOX2 JICL38 WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
IOX4 WADA S2: Peptide Hormones, Growth Factors, etc.; DoDI 1010.16 OPSS entry
ipamorelin WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
isobutyryl fentanyl N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide DEA Controlled Substance List: Schedule I OPSS entry
isomethadone isomethadone II; Win 1783; 1,1-diphenyl-1-(dimethylaminoisopropyl)butanone-2; isoamidone; isoamidone II (+1) DEA Controlled Substance List: Schedule II; DoDI 1010.16 OPSS entry
isometheptene isonyl; octanil; octinum; 5-hepten-2-amine, N,6-dimethyl-; octin FDA Statement FDA Statement
isopropylnorsynephrine Deterenol; isopropyloctopamine; N-isopropyloctopamine; Betaphrine; N-isopropylnorsynephrine Unapproved Drug; FDA Statement FDA: New dietary ingredient response letter
isotonitazene N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine; N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine DEA Controlled Substance List: Schedule I OPSS entry
isovaleryl fentanyl Isovalerylfentanyl; 3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide; isovalery fentanyl DEA Controlled Substance List: Schedule I OPSS entry
JNJ-28330835 JNJ 28330835; (3 S)-3-methyl-5-trifluoromethyl-3,4-dihydro-2H-pyrazole-3-carboxylic acid N-(4-cyano-3-trifluoromethylphenyl)amide); 1H-pyrazole-5-carboxamide, N-(4-cyano-3-(trifluoromethyl)phenyl)-4,5-dihydro-5-methyl-3-(trifluoromethyl)-, (5S)-; (S)-3-methyl-5-trifluoromethyl-3,4-dihydro-2H-pyrazole-3-carboxylic acid N-(4-cyano-3-trifluoromethylphenyl)amide) WADA S1: Anabolic Agents; FDA Statement Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
ketamine Ketaset; Special K; Ketalar; K; (±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone DEA Controlled Substance List: Schedule III OPSS entry
ketazolam Contamex; Loftran; Solatran; Anxon DEA Controlled Substance List: Schedule IV OPSS entry
ketobemidone Cliradon DEA Controlled Substance List: Schedule I OPSS entry
kisspeptin WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
kratom ithang; kakuam; madat; mambog; cratom (+25) Military policy; FDA Statement ALNAV 003/26
lacosamide (R)-2-acetoamido-N-benzyl-3-methoxy-propionamide; Vimpat DEA Controlled Substance List: Schedule V OPSS entry
landogrozumab anti-myostatin antibody WADA S4: Hormone and Metabolic Modulators OPSS entry
lasmiditan Reyvow; 2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide DEA Controlled Substance List: Schedule V OPSS entry
lefetamine (-)-1-dimethylamino-1,2-diphenylethane; SPA; 1-dimethylamino-1,2-diphenylethane DEA Controlled Substance List: Schedule IV OPSS entry
lemborexant (1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide DEA Controlled Substance List: Schedule IV OPSS entry
lenomorelin ghrelin; ghrelin human WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
letrozole 4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile); HSDB 7461; CGS20267; CCRIS 8822; 4-[(4-Cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile (+5) WADA S4: Hormone and Metabolic Modulators; Prescription drug NIH NCATS Inxight Drugs entry: Letrozole
leuprorelin leuprolide WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Leuprolide
levo-alphacetylmethadol LAAM; levo-alpha-acetylmethadol; levomethadyl acetate DEA Controlled Substance List: Schedule II OPSS entry
levomethamphetamine levmetamfetamine; l-methamphetamine DoDI 1010.16; OTC drug NIH NCATS Inxight Drugs entry: Levmetamfetamine
levomethorphan methorphan; l-methorphan DEA Controlled Substance List: Schedule II OPSS entry
levomoramide levoramide; (3R)-3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin-1-ylbutan-1-one DEA Controlled Substance List: Schedule I OPSS entry
levophenacylmorphan (-)-3-hydroxy-N-phenacylmorphinan; benzorphanol DEA Controlled Substance List: Schedule I OPSS entry
levorphanol Levo-Dromoran DEA Controlled Substance List: Schedule II OPSS entry
levosalbutamol levalbuterol WADA S3: Beta-2 Agonists; Prescription drug NIH NCATS Inxight Drugs entry: Levalbuterol
LGD-2226 6-(bis-(2,2,2-trifluoroethyl)amino)-4-trifluoromethyl-1H-quinolin-2-one; LGD2226 WADA S1: Anabolic Agents; FDA Statement Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
LGD-3303 LGD3303; 7H-pyrrolo(3,2-F)quinolin-7-one, 9-chloro-2-ethyl-3,6-dihydro-1-methyl-3-(2,2,2-trifluoroethyl)-; LGD-3033; 9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo[3,2-f]quinolin-7(6H)-one; LGD 3033 (+1) WADA S1: Anabolic Agents; FDA Statement Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
LGD-4033 4-[(2R)-w-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile; 4-((R)-2-((R)-2,2,2-Trifluoro-1-hydroxyethyl)pyrrolidin-1-yl)-2-(trifluoromethyl)benzonitrile; Ligandrol; anabolicum; LGD4033 (+2) WADA S1: Anabolic Agents; FDA Statement Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
lisdexamfetamine Vyvanse DEA Controlled Substance List: Schedule II OPSS entry
lonapegsomatropin Skytrofa; lonapegsomatropin-tcgd; TRANSCONPEG HGH WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Lonapegsomatropin
long R3-IGF-1 WADA S2: Peptide Hormones, Growth Factors, etc.; DoDI 1010.16 OPSS entry
loprazolam DEA Controlled Substance List: Schedule IV OPSS entry
lorazepam Ativan DEA Controlled Substance List: Schedule IV OPSS entry
lorcaserin Belviq DEA Controlled Substance List: Schedule IV OPSS entry
lormetazepam Noctamid DEA Controlled Substance List: Schedule IV OPSS entry
luspatercept Reblozyl WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Luspatercept
luteinizing hormone LH; luteinising hormone WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
lysergic acid D-lysergic acid; (8R)-9,10-didehydro-6-methylergoline-8-carboxylic acid; ergoline acid DEA Controlled Substance List: Schedule III OPSS entry
lysergic acid amide D-lysergic acid amide; lysergamide; ergine DEA Controlled Substance List: Schedule III OPSS entry
lysergic acid diethylamide lysergide; LSD DEA Controlled Substance List: Schedule I OPSS entry
m-hydroxybenzoylecgonine mOHBE; 3-hydroxybenzoylecgonine DoDI 1010.16 OPSS entry
m-hydroxycocaine 3'-hydroxybenzoylecgonine methyl ester; 3'-hydroxycocaine DoDI 1010.16 OPSS entry
MAB-CHMINACA ADB-CHMINACA; N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
macimorelin WADA S2: Peptide Hormones, Growth Factors, etc.; Discontinued drug NIH NCATS Inxight Drugs entry: Macimorelin
marihuana weed; marijuana; marihuana extract DEA Controlled Substance List: Schedule I OPSS entry
mazindol Mazanor; Sanorex DEA Controlled Substance List: Schedule IV OPSS entry
MDA N-hydroxy-3,4-methylenedioxyamphetamine; Love Drug; tenamfetamine; methylenedioxyamphetamine; 3,4-methylenedioxy amphetamine (+3) DEA Controlled Substance List: Schedule I OPSS entry
MDEA MDMB; 3,4-methylenedioxy-N-ethylamphetamine; MDE; N-ethyl MDA; N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine DEA Controlled Substance List: Schedule I OPSS entry
MDMA Ectasy; 3,4-methylenedioxymethamphetamine; XTC; methylenedioxymethamphetamine DEA Controlled Substance List: Schedule I OPSS entry
MDMB-4en-PINACA methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate DEA Controlled Substance List: Schedule I OPSS entry
MDMB-CHMICA methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate; MMB-CHMINACA; MDMB–CHMICA; MMB–CHMINACA DEA Controlled Substance List: Schedule I OPSS entry
MDMB-FUBINACA methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate; MDMB–FUBINACA DEA Controlled Substance List: Schedule I OPSS entry
MDPV 3,4-methylenedioxypyrovalerone; 1-(1,3-benzodioxol-4-yl)-2-(pyrrolidin-1-yl)pentan-1-one (2,3-methylenedioxy pyrovalerone); 1-(1,3-benzodioxol-5-yl)-2-(cyclohexylamino)propan-1-one(n-cyclohexylmethylone); 3,4-methylenedioxy-α-cyclohexylaminopropiophenone DEA Controlled Substance List: Schedule I OPSS entry
mebolazine 17-beta-hydroxy-2alpha,17-dimethyl-5-alpha-androstan-3-one azine; mebulazina; dimetazin; 17-β-hydroxy-2-α,17-dimethyl-5-α-androstan-3-one azine; Dostalon (+13) WADA S1: Anabolic Agents; FDA Warning Letter FDA Warning Letter
mebutamate Capla DEA Controlled Substance List: Schedule IV OPSS entry
meclofenoxate Analux; meclophenoxate; Proseryl; Cetrexin; Lucidril (+4) Unapproved Drug NIH NCATS Inxight Drugs entry: Meclofenoxate
mecloqualone Nubarene DEA Controlled Substance List: Schedule I OPSS entry
medazepam Nobrium DEA Controlled Substance List: Schedule IV OPSS entry
mefenorex Doracil; Amexate; Anorexic; Pondinil DEA Controlled Substance List: Schedule IV OPSS entry
meldonium MET-88; Q-4224-IOS; mildronate; 2-(2-carboxyethyl)-1,1,1-trimethyl hydrazinium hydroxide inner salt; mildronat (+11) WADA S4: Hormone and Metabolic Modulators OPSS entry
mentabolan (7alpha)-7-methylestr-4-ene-3,17-dione; 7alpha-methyl-estra-4-en-3,17-dione; 7α-methyl-estra-4-en-3,17-dione; 7α-methylestr-4-ene-3,17-dione; (7α,14β)-7-methylestra-4-ene-3,17-dione (+14) FDA Warning Letter FDA Warning Letter
mephedrone Mcat; buphedrone; N,N-dimethyl-cathinone; 3-methyl-methcathinone; 4-methylmethcathinone (+3) DEA Controlled Substance List: Schedule I OPSS entry
mephentermine mephenterdrinum; mephentermine sulfate; mefentermina; mefenterdrin; Wyfentermina (+5) Unapproved Drug NIH NCATS Inxight Drugs entry: Mephentermine
meprobamate Meprospan; Miltown; Micrainin; Equanil; Equagesic DEA Controlled Substance List: Schedule IV OPSS entry
mescaline 3,4,5-trimethoxyphenethylamine DEA Controlled Substance List: Schedule I OPSS entry
mesocarb N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate DEA Controlled Substance List: Schedule I OPSS entry
mestanolone 17a-methyl-d1-dihydrotestosterone; Tantarone; 17α-methyl-17β-hydroxy-5α-androstan-3-one; Methybol; 17alpha-methyl-17beta-hydroxy-5alpha-androstan-3-one (+2) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
mesterolone 1α-methyl-17β-hydroxy-[5α]-androstan-3-one; 17β-hydroxy-1α-methyl-5α-androstan-3-one; 1alpha-methyl-17beta-hydroxy-5alphaandrostan-3-one; Testiwop; Androviron (+5) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
meta-fluorofentanyl N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide DEA Controlled Substance List: Schedule I OPSS entry
meta-fluoroisobutyryl fentanyl N-(3-fluorophenyl)-N-(1-phenylpiperidin-4-yl)isobutyramide; meta-fluoroisobutylryl fentanyl DEA Controlled Substance List: Schedule I OPSS entry
metazocine 2,6-methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3,6,11-trimethyl-; methobenzmorphan DEA Controlled Substance List: Schedule II OPSS entry
methadone Methadose; Amidone; Dolophine DEA Controlled Substance List: Schedule II OPSS entry
methadone-intermediate 4-cyano-2-dimethylamino-4,4-diphenyl butane DEA Controlled Substance List: Schedule II OPSS entry
methamphetamine metamfetamine(d-); ICE; Desoxyn; Speed; d-methamphetamine (+2) DEA Controlled Substance List: Schedule II OPSS entry
methandienone metabolina; dianabol; methandrostenolone; 17α-methyl-17β-hydroxyandrost-1,4-dien-3-one; 17alpha-methyl-17beta­-hydroxyandrost-1,4-dien-3-one (+7) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
methandriol androdiol; 17α-methyl-3β,17β-dihydroxyandrost-5-ene; Troformone; Stenediol; 17alpha-methyl-3beta,17beta-dihydroxyandrost-5-ene (+6) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
methaqualone Quaalude; Somnafac; Parest; Mandrax; Opitimil DEA Controlled Substance List: Schedule I OPSS entry
methasterone 2alpha,17alpha-dimethyl-5alphaandrostan-17beta-ol-3-one; 17β-hydroxy-2α,17α-dimethyl-5α-androstan-3-one; superdrol; 2α,17α-dimethyl-5α-androstan-17β-ol-3-one; 17beta-hydroxy-2alpha,17alpha-dimethyl-5alpha-androstan-3-one (+4) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
methcathinone monomethylpropion; 2-(methylamino)-propiophenone; AL-463; AL-464; methylcathinone (+8) DEA Controlled Substance List: Schedule I OPSS entry
methenolone 1-methyl-17β-hydroxy-5α-androst-1-en-3-one; Primobolan; Primobolan Depot; metenolone; (5α,17β)-17-hydroxy-1-methylandrost-1-en-3-one (+4) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
methiopropamine N-methyl-1-(thiophen-2-yl)propane-2-amine DEA Controlled Substance List: Schedule I OPSS entry
methohexital Brevital; methohexitone; methohexitone sodium DEA Controlled Substance List: Schedule IV OPSS entry
methoxy polyethylene glycol-epoetin beta MIRCERA® WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Methoxy polyethylene glycol-epoetin beta
methoxyacetyl fentanyl 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide DEA Controlled Substance List: Schedule I OPSS entry
methoxydienone 13-ethyl-3-methoxy-gona-2,5(10)-diene-17-one; methoxygonadiene; 13-beta-Ethyl-3-methoxy-gona-2,5(10)-dien-17-one; MAX-LMG; Max LMG WADA S1: Anabolic Agents; FDA Warning Letter FDA warning letter
methoxyphedrine methedrone; 4-methoxymethcathinone DEA Controlled Substance List: Schedule I OPSS entry
methyl-1-testosterone 17alpha-methyl-delta1-dihydrotestosterone; 17beta-hydroxy-17alpha-methyl-5alpha-androst-1-en-3-one; 17-alpha-methyl-1-testosterone; 17α-methyl-Δ1-dihydrotestosterone; 17-α-methyl-1-testosterone (+1) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
methylclostebol 4-chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one; 4-Chloro-17β-hydroxy-17α-methylandrost-4-en-3-one; 4-chloro-17alpha-methyl-17beta-hydroxy-androst-4-en-3-one DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
methyldesorphine MK 57; 3-hydroxy-6,N-dimethyl-4,5-epoxymorphin-6-en DEA Controlled Substance List: Schedule I OPSS entry
methyldienolone 17alpha-methyl-17beta-hydroxyestra4,9(10)-dien-3-one; 17beta-hydroxy-17alpha-methylestra-4,9-dien-3-one; 17β-hydroxy-17α-methylestra-4,9-dien-3-one; 17α-methyl-17β-hydroxyestra-4,9(10)-dien-3-one DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
methyldihydromorphine methyl dihydromorphine; morphine, methyldihydro- DEA Controlled Substance List: Schedule I OPSS entry
methylephedrine N-methylephedrine hydrochloride; methylpseudoephedrine; Tybraine; N-methylephedrine Other reason Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk
methylnaphthidate 2-piperidineacetic acid, α-2-naphthalenyl-, methyl ester; HDMP-28; methyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate; 2-piperidineacetic acid, alpha-2-naphthalenyl-, methyl ester; DL-threo-methylnaphthidate Unapproved Drug NIH NCATS Inxight Drugs entry: Methylnaphthidate
methylone 2,3-methylenedioxymethcathinone; 1-(benzo[d][1,3]dioxol-4-yl)-2-(methylamino)propan-1-one); 2,3-MDMC; 3,4-methylenedioxy-N-methylcathinone DEA Controlled Substance List: Schedule I OPSS entry
methylphenidate Tsentedrin; Concerta®; Ritalin®SR; Cotempla®XR-ODT; Aptensio XR® (+19) DEA Controlled Substance List: Schedule II OPSS entry
methylphenobarbital mephobarbital; Mebaral DEA Controlled Substance List: Schedule IV OPSS entry
methylstenbolone 2,17a-dimethyl-17b-hydroxy-5a-androst-1-en-3-one; M-Sten; Ultradrol WADA S1: Anabolic Agents; FDA Warning Letter FDA Warning Letter
methylsynephrine 1-(4-hydroxyphenyl)-2-methylaminopropanol; Oxyephedrin; 4‐[1‐hydroxy‐2‐(methylamino)propyl]phenol; Suprifene; Supriphen (+16) FDA Statement FDA: Methylsynephrine in Dietary Supplements
methyltestosterone Virilon; 17α-methyl-17β-hydroxyandrost-4-en-3-one; 17alpha-methyl-17beta-­hydroxyandrost-4-en-3-one; 17β-hydroxy-17α-methylandrost-4-en-3-one; Android (+3) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
methylthioninium chloride methylene blue anhydrous; methylene blue; methylene blue Prescription drug NIH NCATS Inxight Drugs entry: Methylene blue
methyltrienolone metribolone; 17beta-hydroxy-17alpha-methylestra-4,9,11-trien-3-one; 17β-hydroxy-17α-methylestra-4,9,11-trien-3-one; 17α-methyl-17β-hydroxyestra-4,9-11-trien-3-one; 17alpha-methyltrienolone DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
methyprylon Noludar DEA Controlled Substance List: Schedule III OPSS entry
metodesnitazene N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine; 2-(2-(4-methoxybenzyl)-1H-benzo[d]imidazol-1-yl)-N,N-diethylethanamine; N,N-diethyl-N-(2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethyl)amine; benzimidazole, 1-(2-(diethylamino)ethyl)-2-(p-methoxybenzyl)-; N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethanamine (+2) DEA Controlled Substance List: Schedule I OPSS entry
metolazone Zaroxolyn®; Mykrox® WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Metolazone
metonitazene N,N-diethyl-2-[(4-methoxyphenyl)methyl]-5-nitro-1H-benzimidazole-1-ethanamine; benzimidazole, 1-(2-(diethylamino)ethyl)-2-(p-methoxybenzyl)-5-nitro-; N,N-diethyl-2-[2-[(4-methoxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]ethanamine; 1H-benzimidazole-1-ethanamine, N,N-diethyl-2-((4-methoxyphenyl)methyl)-5-nitro-; N,N-diethyl-2-((4-methoxyphenyl)methyl)-5-nitro-1H-benzimidazole-1-ethanamine (+2) DEA Controlled Substance List: Schedule I OPSS entry
metopon dihydro-6-methylmorphinone; methyldihydromorphinone; 5-methyldihydromorphinone; 5-methylhydromorphone DEA Controlled Substance List: Schedule II OPSS entry
MGM-15 dihydro-7-hydroxymitragynine DEA Controlled Substance List: Schedule I OPSS entry
MGM-16 9-fluoro-dihydro-7-hydroxymitragynine DEA Controlled Substance List: Schedule I OPSS entry
mibolerone 7alpha,17alpha-dimethyl-17beta-­hydroxyestr-4-en-3-one; Cheque; Cheque drops; Matenon; 7α,17α-dimethyl-17β-hydroxyestr-4-en-3-one (+1) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
midazolam Versed DEA Controlled Substance List: Schedule IV OPSS entry
mitochondrial open reading frame of the 12S rRNA-c MOTS-c; mitochondrial open reading frame of the 12S rRNA-c (MOTS-c) WADA S4: Hormone and Metabolic Modulators OPSS entry
mitragynine pseudoindoxyl pseudoindoxyl; MP; MGPI DEA Controlled Substance List: Schedule I OPSS entry
MK-677 mk677; ibutamoren mesylate; MK 0677; Crescendo; 2-amino-N-((R)-2-(benzyloxy)-1-((1-(methylsulfonyl)spiro(indoline-3,4'-piperidin)-1'-yl)carbonyl)ethyl)-2-methyl-propionamide monomethanesulfonate (+5) WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
MMB-CHMICA methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate; AMB-CHMICA DEA Controlled Substance List: Schedule I OPSS entry
MMB-FUBICA methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate DEA Controlled Substance List: Schedule I OPSS entry
MMDA 5-methoxy-3,4-methylenedioxy-amphetamine; 5-methoxy-3,4-methylenedioxyamphetamine DEA Controlled Substance List: Schedule I OPSS entry
modafinil benzhydrylsulfinylacetamide; Sparlon; modafinilum; Provigil; modafinilo (+3) DEA Controlled Substance List: Schedule IV OPSS entry
molidustat BAY 85-3934 WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
moramide-intermediate 2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid DEA Controlled Substance List: Schedule II OPSS entry
morpheridine TA 1; ethyl 1-(2-morpholin-4-ylethyl)-4-phenylpiperidine-4-carboxylate; morpholinoethyl-norpethidine DEA Controlled Substance List: Schedule I OPSS entry
morphine morphine methylsulfonate; morphine methylbromide; Roxanol; Oramorph; MSIR (+3) DEA Controlled Substance List: Schedule II OPSS entry
mozavaptan WADA S5: Diuretics and Masking Agents OPSS entry
MPHP 4'-methyl-alpha-pyrrolidinohexiophenone; 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one; 4'-methyl-alpha-pyrrolidinohexanophenone DEA Controlled Substance List: Schedule I OPSS entry
MPPP 1-methyl-4-phenyl-4-propionoxypiperidine DEA Controlled Substance List: Schedule I OPSS entry
MT-45 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine DEA Controlled Substance List: Schedule I OPSS entry
myo-inositol trispyrophosphate ITPP; ITPP cpd; OXY111A; inositol trispyrophosphate Military policy DoDI 6130.06 Use of Dietary Supplements in the DoD
myostatin propeptide WADA S4: Hormone and Metabolic Modulators OPSS entry
myrophine benzylmorphinyl myristate; myrophinium; myristylbenzylmorphine; 3-benzylmorphine 6-myristate; 3-benzyloxy-6-myristoyloxymorphine (+1) DEA Controlled Substance List: Schedule I OPSS entry
N,N-dimethylamphetamine N,N-alpha-trimethylphenethylamine; dimethylamphetamine; dimetamfetamine; N,N-alpha-trimethyl-benzeneethanamine DEA Controlled Substance List: Schedule I OPSS entry
N,N-dimethylethylamine 1,3-dimethylethylamine; dimethylethylamine; DMEA; ethanamine, N,N-dimethyl-; ethylamine, N,N-dimethyl- (+5) Other reason Toxic volatile industrial chemical
N-benzylpiperazine 1-benzylpiperazine tartrate; 1-benzylpiperazine dihydrochloride; benzylpiperazine; BZP; 1-benzylpiperazine fumarate (+3) DEA Controlled Substance List: Schedule I OPSS entry
N-ethyl-1-phenylcyclohexylamine PCE; (1-phenylcyclohexyl)ethylamine; cyclohexamine; N-(1-phenylcyclohexyl)ethylamine; ethylamine analog of phencyclidine DEA Controlled Substance List: Schedule I OPSS entry
N-ethyl-3-piperidyl benzilate JB 323 DEA Controlled Substance List: Schedule I OPSS entry
N-ethyl-N-methylcathinone DEA Controlled Substance List: Schedule I OPSS entry
N-ethylamphetamine ethylamphetamine; etilamfetamine; NEA; Adiparthrol; Apetinil DEA Controlled Substance List: Schedule I OPSS entry
N-ethylbuphedrone NEB DEA Controlled Substance List: Schedule I OPSS entry
N-ethylhexedrone 2-(ethylamino)-1-phenylhexan-1-one DEA Controlled Substance List: Schedule I OPSS entry
N-ethylpentylone βk-ethyl-K; β-keto-ethylbenzodioxolylpentanamine; βk-EBDP; ephylone; 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one DEA Controlled Substance List: Schedule I OPSS entry
N-methyl-3-piperidyl benzilate JB 336 DEA Controlled Substance List: Schedule I OPSS entry
N-methyltyramine p-(2-(Methylamino)ethyl)phenol; methyl tyramine; NMT; p-(2-methylaminoethyl)phenol; 4-[2-(methylamino)ethyl]phenol (+10) FDA Warning Letter FDA Warning Letter
N-pyrrolidino etonitazene (2-(4-ethoxybenzyl)-5-nitro-1-(2- (pyrrolidin-1-yl)ethyl)-1H-benzimidazole); 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)1Hbenzimidazone; 2-[(4-ethoxyphenyl)methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)benzimidazole; etonitazepyne ; 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzo(d)imidazole DEA Controlled Substance List: Schedule I OPSS entry
nabilone Cesamet; (+)-trans-3-(1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1-hydroxy-6, 6-dimethyl-9H-dibenzo[b,d]pyran-9-one DEA Controlled Substance List: Schedule II OPSS entry
nafarelin LHRH, 6(D-NAL(2)) WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Nafarelin
nalorphine Nalline DEA Controlled Substance List: Schedule III OPSS entry
nandrolone nandrolone enanthate; duraboin; 19-nortestosterone; 17β-hydroxyestr-4-en-3-one; deca-durabolin (+5) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
naphthalene albocarbon; dezodorator; tar camphor; white tar DoDI 1010.16 OPSS entry
naphyrone α-naphyrone; 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one; naphthylpyrovalerone DEA Controlled Substance List: Schedule I OPSS entry
nefiracetam N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide; N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide; 2-oxo-1-pyrrolidineaceto-2',6'-xylidide Unapproved Drug NIH NCATS Inxight Drugs entry: Nefiracetam
nicocodeine nicocodine; 6-nicotinoylcodeine; lyopect; nicotinic acid, ester with codeine DEA Controlled Substance List: Schedule I OPSS entry
nicomorphine Vilan DEA Controlled Substance List: Schedule I OPSS entry
nimetazepam methylnitrazepam; 1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one; Elimin; Erimin DEA Controlled Substance List: Schedule IV OPSS entry
nitrazepam Mogadon DEA Controlled Substance List: Schedule IV OPSS entry
NM2201 naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate; CBL2201 DEA Controlled Substance List: Schedule I OPSS entry
nor-NOHA butanoic acid, 2-amino-4-(((hydroxyamino)iminomethyl)amino)-, (S)-; N-omega-hydroxy-L-norarginine; (2S)-4-[[amino-(hydroxyamino)methylidene]amino]-2-azaniumylbutanoate; Nomega-hydroxy-nor-L-arginine; N-omega-hydroxynor-L-arginine (+5) Unapproved Drug NIH NCATS Inxight Drugs entry: nor-NOHA
noracymethadol [6-(methylamino)-4,4-diphenylheptan-3-yl] acetate; paracymethadol DEA Controlled Substance List: Schedule I OPSS entry
norandrostenediol 19-nor-4-androstenediol; 19-nor-androstenediol; bolandiol; 3β-dihydronandrolone; 3beta-dihydronandrolone (+8) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
norandrostenedione bolandione; 19-nor-4-androstenedione; 19-norandrost-4-ene-3,17-dione; 19-norandrost-4-en-3,17-dione; estr-4-ene-3β,17-dione (+5) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
norbenzoylecgonine NBE; benzoylnorecgonine DoDI 1010.16 OPSS entry
norbolethone norboletone; 13β,17α-diethyl-17β-hydroxygon-4-en-3-one; 17α-Ethyl-17β-hydroxy-18-methylestr-4-en-3-one; 13beta,17alpha-diethyl-17beta-­hydroxygon-4-en-3-one; Genabol DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
norclostebol 4-chloro-17β-hydroxyestr-4-en-3-one; 4-chloro-17β-ol-estr-4-en-3-one; 4-chloro-17beta-hydroxyestr-4-en-3-one; Lentabol; Anabol-4-19 (+1) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
norcocaine n-demethylcocaine DoDI 1010.16 OPSS entry
nordiazepam nordazepam; dealkylprazepam; Madar; desmethyldiazepam; norprazepam (+1) DEA Controlled Substance List: Schedule IV OPSS entry
norethandrolone 17alpha-ethyl-17beta-hydroxyestr-4en-3-one; Pronabol; Solevar; Nilevar; 17α-ethyl-17β-hydroxyestr-4-en-3-one DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
norfenfluramine DoDI 1010.16 OPSS entry
norfentanyl N-phenyl-N-(piperidin-4-yl)propionamide DEA Controlled Substance List: Schedule II OPSS entry
norlevorphanol 3-hydroxymorphinan; morphinan-3-ol DEA Controlled Substance List: Schedule I OPSS entry
normethadone phenyldimazone DEA Controlled Substance List: Schedule I OPSS entry
normethandrolone methylestrenolone; 17β-hydroxy-17α-methylestr-4-en-3-one; methylnortestosterone; Matronal; 17α-methyl-19-nortestosterone (+2) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
normorphine DEA Controlled Substance List: Schedule I OPSS entry
noroxymorphone 7,8-dihydro-14-hydroxynormorphinone; (5alpha)-4,5-Epoxy-3,14-dihydroxymorphinan-6-one DEA Controlled Substance List: Schedule II OPSS entry
norpipanone Hoechst 10495; Orfenso; 3-hexanone, 4,4-diphenyl-6-(1-piperidinyl)- DEA Controlled Substance List: Schedule I OPSS entry
nortadalafil Unapproved Drug; FDA Warning Letter FDA Warning Letter
Nymphaea caerulea blue lotus; blue lotus (Nymphaea caerulea); Egyptian water lily; nuciferine; apomorphine Military policy DoDI 1010.04 Problematic Substance Use by DoD Personnel and DoDI 6130.06 Use of Dietary Supplements in the DoD
octopamine 4-(2-amino-1-hydroxyethyl)phenol; Norden; 1-(p-hydroxyphenyl)-2-aminoethanol; alpha-aminoethyl-4-hydroxybenzylalkohol; Norphen (+14) FDA Warning Letter FDA Warning Letter
oliceridine N-[(3-methoxythiophen-2-yl)methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl})amine fumarate; N-[(3-methoxythiophen-2-yl)methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl{time} )amine fumarate; N-[(3-Methoxythiophen-2-yl)methyl]-2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethanamine DEA Controlled Substance List: Schedule II OPSS entry
olodaterol WADA S3: Beta-2 Agonists; Prescription drug NIH NCATS Inxight Drugs entry: Olodaterol
omberacetam GVS 111; Noopept; ethyl phenylacetyl-pro-gly; GVS-111; noopept (N-phenylacetyl-L-prolyglycine ethyl ester) (+1) Unapproved Drug DoJ Press Release
opium paregoric; opium, raw; opium fluid extract; powdered opium; gum opium (+10) DEA Controlled Substance List: Schedule II OPSS entry
oripavine DEA Controlled Substance List: Schedule II OPSS entry
ortho-fluoroacryl fentanyl N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide DEA Controlled Substance List: Schedule I OPSS entry
ortho-fluorobutyryl fentanyl N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; 2-fluorobutyryl fentanyl DEA Controlled Substance List: Schedule I OPSS entry
ortho-fluorofentanyl N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide; 2-fluorofentanyl DEA Controlled Substance List: Schedule I OPSS entry
ortho-fluorofuranyl fentanyl N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
ortho-fluoroisobutyryl fentanyl N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide DEA Controlled Substance List: Schedule I OPSS entry
ortho-methyl acetylfentanyl 2-methylacetylfentanyl; N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide DEA Controlled Substance List: Schedule I OPSS entry
ortho-methyl methoxyacetylfentanyl 2-methyl methoxyacetyl fentanyl; 2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide DEA Controlled Substance List: Schedule I OPSS entry
osilodrostat Isturisa WADA S1: Anabolic Agents; Prescription drug NIH NCATS Inxight Drugs entry: Osilodrostat
ospemifene 2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol; 2-(p-((Z)-4-chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol; Osphena; CCRIS 9205; Fc-1271 (+5) WADA S4: Hormone and Metabolic Modulators; Prescription drug NIH NCATS Inxight Drugs entry: Ospemifene
oxabolone 4,17beta-dihydroxyestr-4-en-3-one; 4,17β-dihydroxy-estr-4-en-3-one; 4,17β-dihydroxyestr-4-en-3-one; 19-norandrost-4-ene-4,17β-diol-3-one; 4-hydroxy-19-nortestosterone DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
oxandrolone Protivar; SC 11585; SC11585; 2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5alpha,17beta)-; Oxandrin (+14) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
oxazepam Serenid-D; Serax DEA Controlled Substance List: Schedule IV OPSS entry
oxazolam Convertal; Serenal DEA Controlled Substance List: Schedule IV OPSS entry
oxiracetam 4-hydroxy-2-oxo-pyrrolidinacetamide Unapproved Drug FDA Designated Orphan Drug
oxycodone OxyContin; Roxicodone; Endocet; Percocet; Roxicet DEA Controlled Substance List: Schedule II OPSS entry
oxyguno 4-chloro-17alpha-methyl-17beta-hydroxy-androst-4-ene-3,11-dione; 4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione DEA Controlled Substance List: Schedule III OPSS entry
oxymesterone Oranabol 10; Balnimax; 17alpha-methyl-4,17beta-dihydroxyandrost-4-en-3-one; 4,17β-dihydroxy-17α-methylandrost-4-en-3-one; Anamidol (+3) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
oxymetholone 17β-hydroxy-2-hydroxymethylene-17α-methyl-5α-androstan- 3-one; anasterone; Anadrol; 17β-Hydroxy-2-hydroxymethylidene-17α-methyl-3-androstanone; Pardroyd (+7) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
oxymorphone Numorphan DEA Controlled Substance List: Schedule II OPSS entry
p-hydroxybenzoylecgonine pOHBE; 4-hydroxybenzoylecgonine DoDI 1010.16 OPSS entry
p-hydroxycocaine 4'-hydroxybenzoylecgonine methyl ester; 4'-hydroxycocaine DoDI 1010.16 OPSS entry
para-chloroisobutyryl fentanyl N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide DEA Controlled Substance List: Schedule I OPSS entry
para-fluoro furanyl fentanyl N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
para-fluorobutyryl fentanyl N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide DEA Controlled Substance List: Schedule I OPSS entry
para-fluorofentanyl N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide DEA Controlled Substance List: Schedule I OPSS entry
para-methoxybutyryl fentanyl N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide DEA Controlled Substance List: Schedule I OPSS entry
para-methoxyfuranyl fentanyl N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
para-methoxymethamphetamine PMMA; 1-(4-methoxyphenyl)-N-methylpropan-2-amine DEA Controlled Substance List: Schedule I OPSS entry
para-methylcyclopropyl fentanyl N-(4-methylphenyl)-N-(1-phenylpiperidin-4-yl)cyclopropanecarboxamide; para-methylcyclopropylfentanyl; N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide DEA Controlled Substance List: Schedule I OPSS entry
para-methylfentanyl 4-methylfentanyl; N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide DEA Controlled Substance List: Schedule I OPSS entry
parahexyl Synhexyl; 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran DEA Controlled Substance List: Schedule I OPSS entry
paraldehyde Paral DEA Controlled Substance List: Schedule IV OPSS entry
PCC 1-piperidinocyclohexanecarbonitrile DEA Controlled Substance List: Schedule II OPSS entry
peginesatide hematide WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
pegmolesatide WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
pemoline Cylert DEA Controlled Substance List: Schedule IV OPSS entry
pentazocine Talacen; Talwin NX; Talwin Compound; Talwin DEA Controlled Substance List: Schedule IV OPSS entry
pentedrone 4-methylbuphedrone; 2-(methylamino)-1-phenylpentan-1-one; α-methylaminovalerophenone DEA Controlled Substance List: Schedule I OPSS entry
pentobarbital Nembutal DEA Controlled Substance List: Schedule II OPSS entry
pentylone propylone; bk-DMBDB; 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1- one; bk-MBDP; 3',4'-methylenedioxy-N-propylaminocathinone (+3) DEA Controlled Substance List: Schedule I OPSS entry
PEPAP 1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine DEA Controlled Substance List: Schedule I OPSS entry
perampanel Fycompa; 2-(2-oxo-l-phenyl-5-pyridin-2-yl-l,2-dihydropyridin-3-yl) benzonitrile DEA Controlled Substance List: Schedule III OPSS entry
pethidine meperidine; Demerol; Mepergan DEA Controlled Substance List: Schedule II OPSS entry
pethidine-intermediate-A 4-cyano-1-methyl-4-phenylpiperidine; meperedine intermediate-A DEA Controlled Substance List: Schedule II OPSS entry
pethidine-intermediate-B ethyl-4-phenylpiperidine-4-carboxylate; normeperidine; meperedine intermediate-B DEA Controlled Substance List: Schedule II OPSS entry
pethidine-intermediate-C 1-methyl-4-phenylpiperidine-4-carboxylic acid; meperedine intermediate-C DEA Controlled Substance List: Schedule II OPSS entry
petrichloral Pentaerythritol chloral; Periclor DEA Controlled Substance List: Schedule IV OPSS entry
peyote Lophophora williamsii Lemaire DEA Controlled Substance List: Schedule I OPSS entry
phenadoxone 6-morpholino-4,4-diphenyl-3-heptanone; 4,4-diphenyl-6-morpholino-3-heptanone; phenodoxone DEA Controlled Substance List: Schedule I OPSS entry
phenampromide N-(1-methyl-2-piperidinoethyl)propionanilide; fenampromide; phenampromid DEA Controlled Substance List: Schedule I OPSS entry
phenazocine Prinadol; Narphen DEA Controlled Substance List: Schedule II OPSS entry
phencyclidine Semylan; 1-(1-phenylcyclohexyl)piperidine; PCP DEA Controlled Substance List: Schedule II OPSS entry
phendimetrazine Prelu-2; Statobex; Melfiat; Bontril; Plegine DEA Controlled Substance List: Schedule III OPSS entry
phenibut β-phenyl-GABA; aminophenylbutyric acid; phenygam; phenigam; phenylgamma (+19) FDA Statement FDA: Phenibut in Dietary Supplements
phenmetrazine Preludin DEA Controlled Substance List: Schedule II OPSS entry
phenobarbital Bellergal-S; Luminal DEA Controlled Substance List: Schedule IV OPSS entry
phenomorphan DEA Controlled Substance List: Schedule I OPSS entry
phenoperidine Operidine; Lealgin DEA Controlled Substance List: Schedule I OPSS entry
phentermine Phentrol; Lonamin; Fastin; normephentermine; phentermine hydrochloride (+14) DEA Controlled Substance List: Schedule IV OPSS entry
phenyl fentanyl benzoyl fentanyl; N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide DEA Controlled Substance List: Schedule I OPSS entry
phenylacetone P2P; benzyl methyl ketone; methyl benzyl ketone; phenyl-2-propanone DEA Controlled Substance List: Schedule II OPSS entry
pholcodine Lantuss; Pholcolin; Adaphol; Codisol; Copholco DEA Controlled Substance List: Schedule I OPSS entry
picamilon 4-(pyridine-3-carbonylamino) butanoic acid; pikamilon; monosodium 4-((3-pyridinylcarbonyl)amino)butanoate; pikatropin; N-nicotinoyl-gamma-aminobutyric acid sodium salt (+7) Unapproved Drug; FDA Statement FDA: Picamilon in Dietary Supplements
piminodine DEA Controlled Substance List: Schedule II OPSS entry
pinazepam Domar DEA Controlled Substance List: Schedule IV OPSS entry
Piper methysticum kava kava; noble kava; kawain; kava; kava root (+4) Military policy DoDI 1010.04 Problematic Substance Use by DoD Personnel and DoDI 6130.06 Use of Dietary Supplements in the DoD
pipradrol Stimolag Fortis; Detaril DEA Controlled Substance List: Schedule IV OPSS entry
piracetam 2-oxo-1-pyrrolidineacetamide; Ciclofalina; Nootropil; 2-pyrrolidinoneacetamide; Pirazetam (+32) FDA Statement FDA Statement
piritramide Piridolan DEA Controlled Substance List: Schedule I OPSS entry
poppy straw concentrate of poppy straw; CPS; poppy heads; opium poppy capsules DEA Controlled Substance List: Schedule II OPSS entry
pralmorelin growth hormone-releasing peptide-2; GHRP-2 WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
pramiracetam 1-pyrrolidineacetamide, N-(2-(bis(1-methylethyl)amino)ethyl)-2-oxo-; CI-879 free base; N-(2-(diisopropylamino)ethyl)-2-oxo-1-pyrrolidineacetamide Unapproved Drug FDA Orphan Drug Designation Withdrawn
prazepam Centrax DEA Controlled Substance List: Schedule IV OPSS entry
pregabalin (S)-3-(aminomethyl)-5-methylhexanoic acid; Lyrica DEA Controlled Substance List: Schedule V OPSS entry
pregnenolone 5-pregnen-3-β-ol-20-one; pregnenolona; delta5-pregnenolone; Skinostelon; Pregnetan (+22) Unapproved Drug Unfinished Drug Product
probenecid Probalan WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Probenecid
procaterol procaterol hydrochloride hydrate; procaterol hydrochloride WADA S3: Beta-2 Agonists OPSS entry
proheptazine dimepheprimine; 1,3-dimethyl-4-phenyl-4-propionyloxyazacycloheptane DEA Controlled Substance List: Schedule I OPSS entry
properidine isopropyl 1-methyl-4-phenylisonipecotate; gevelina; ipropethidine; isopedine DEA Controlled Substance List: Schedule I OPSS entry
propiram Algeril DEA Controlled Substance List: Schedule I OPSS entry
prostanozol 17β-[(Tetrahydro-2H-pyran-2-yl)oxy]-5α-androst-2-eno[3,2- c]pyrazole; 17β-[(tetrahydropyran-2-yl)oxy]-1'H-pyrazolo[3,4:2,3]-5α-androstane; [3,2-c]pyrazole-5alpha-androstan-17beta-ol; 17β-hydroxy-5α-androstano[3,2-c]pyrazole; 17beta-hydroxy-5alpha-androstano[3,2c]pyrazole (+2) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
protonitazene N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1- yl)ethan-1-amine; N,N-diethyl-2-[5-nitro-2-[(4-propoxyphenyl)methyl]benzimidazol-1-yl]ethanamine; propoxynitazene DEA Controlled Substance List: Schedule I OPSS entry
pseudoephedrine pseudoephedrine HCl; (1S,2S)-2-(methylamino)-1-phenylpropan-1-ol; pseudoephedrine hydrochloride; Isoephedrine; d-Isoephedrine (+1) OTC drug FDA: Legal Requirements for the Sale and Purchase of Drug Products Containing Pseudoephedrine…
psilocybin DEA Controlled Substance List: Schedule I OPSS entry
psilocyn psilocin DEA Controlled Substance List: Schedule I OPSS entry
PV8 alpha-pyrrolidinoheptaphenone; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one DEA Controlled Substance List: Schedule I OPSS entry
pyrovalerone Centroton; Thymergix DEA Controlled Substance List: Schedule V OPSS entry
pyrrole 1h-pyrrole; imidole; azole; 1-aza-2,4-cyclopentadiene; divinylenimine DoDI 1010.16 OPSS entry
quazepam Doral DEA Controlled Substance List: Schedule IV OPSS entry
quinbolone 17beta-(1-cyclopenten-1-yloxy)androsta-1,4-dien-3-one; quinbolona; androsta-1,4-dien-3-one, 17-(1-cyclopenten-1-yloxy)-, (17beta); 17beta-(1-cyclopentenyloxy)-1,4-androstadien-3-one; 17β-(1-cyclopentenyloxy)-1,4-androstadien-3-on (+6) WADA S1: Anabolic Agents OPSS entry
quinethazone Hydromox WADA S5: Diuretics and Masking Agents OPSS entry
QUPIC PB-22; quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate DEA Controlled Substance List: Schedule I OPSS entry
R3-IGF-1 WADA S2: Peptide Hormones, Growth Factors, etc.; DoDI 1010.16 OPSS entry
racemethorphan DL-methorphan; 3-methoxy-17-methylmorphinan; racemethorphan hydrobromide DEA Controlled Substance List: Schedule II OPSS entry
racemoramide dimorlin; DL-moramide DEA Controlled Substance List: Schedule I OPSS entry
racemorphan Dromoran DEA Controlled Substance List: Schedule II OPSS entry
ractopamine WADA S1: Anabolic Agents OPSS entry
RAD-150 2-[5-chloropentyl(methyl)amino]-N-(2,6-dimethylphenyl)acetamide; sustalone; TLB-150 benzoate; (2S,3R)-3-[(cyanophenyl)-1,3,4-oxadiazoll-2-yl]-3-[(2-methyl-3-chloro-4-cyanphenyl)amino]-2-propyl alcohol benzoate; (2S,3R)-3-[(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-3-[(2- methyl-3-chloro-4-cyanphenyl)amino]-2-propyl alcohol benzoate (+15) WADA S1: Anabolic Agents; FDA Statement Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
raloxifene Evista; raloxifene hydrochloride; CCRIS 7129; raloxifeno; LY139481 (+8) WADA S4: Hormone and Metabolic Modulators; Prescription drug NIH NCATS Inxight Drugs entry: Raloxifene
reldesemtiv CK-2127107 WADA S0: Non-approved Substances OPSS entry
remifentanil Ultiva DEA Controlled Substance List: Schedule II OPSS entry
remimazolam methyl 3-[(4S)-8-bromo-1-methyl-6-pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin-4yl]propanoate benzenesulfonic acid; 4H-imidazol[1,2-a][1,4]benzodiazepine-4-propionic acid; 8-bromo-1-methyl-6-(2-pyridinyl)-(4S)-methyl ester; benzenesulfonate (1:1); byfavo DEA Controlled Substance List: Schedule IV; Prescription drug NIH NCATS Inxight Drugs entry: remimazolam
reproterol 1H-purine-2,6-dione, 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-3,7-dihydro-1,3-dimethyl-; 7-(3-((beta,3,5-trihydroxyphenethyl)amino)propyl)theophylline; 7-(3-((β,3,5-trihydroxyphenethyl)amino)propyl)theophylline WADA S3: Beta-2 Agonists OPSS entry
rismorelin WADA S2: Peptide Hormones, Growth Factors, etc.; DoDI 1010.16 OPSS entry
roxadustat FG-4592 WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
S-23 3-(4-cyanophenoxy)-N-(4-cyano-3-trifluoromethylphenyl)-2-hydroxy-2-methylpropionamide; 1-phenyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride; CCTH-methylpropionamide; (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide; 1-phenyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (+8) WADA S1: Anabolic Agents; FDA Statement Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
S-40503 S 40503; s 40503; s40503; 2-quinolineethanol, 4-(dimethylamino)-1,2,3,4-tetrahydro-β,β-dimethyl-6-nitro-; 2-(4-(dimethylamino)-6-nitro-1,2,3,4-tetrahydroquinolin-2-YL)-2-methylpropan-1-ol (+2) WADA S1: Anabolic Agents; FDA Statement Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
S48168 (ARM210) WADA S0: Non-approved Substances OPSS entry
salbutamol albuterol WADA S3: Beta-2 Agonists OPSS entry
salmeterol Serevent WADA S3: Beta-2 Agonists; Prescription drug NIH NCATS Inxight Drugs entry: Salmeterol
Salvia divinorum Divine Mexican Mint; Pipiltzintzintli; divinorin A; salvinorin A; Leaves of the Virgin Shepherdess (+15) Military policy Salvia and drug testing
SARM selective androgen receptor modulator; SARMs WADA S1: Anabolic Agents; FDA Statement Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
SARM S1 WADA S1: Anabolic Agents; DoDI 1010.16 OPSS entry
SARM S9 WADA S1: Anabolic Agents; DoDI 1010.16 OPSS entry
secobarbital Quinalbarbitone; Tuinal; Seconal DEA Controlled Substance List: Schedule II OPSS entry
semax Unapproved Drug Unfinished Drug Product
serdexmethylphenidate 3-[[[(1S)-1-carboxy-2-hydroxyethyl]-amino]carbonyl]-1-[[[[(2R)-2-[(1R)-2-methoxy-2-oxo-1-phenylethyl]-1-piperidinyl]carbonyl]oxy]methyl]pyridinium chloride DEA Controlled Substance List: Schedule IV; Prescription drug NIH NCATS Inxight Drugs entry: serdexmethylphenidate
sermorelin Geref WADA S2: Peptide Hormones, Growth Factors, etc.; Discontinued drug NIH NCATS Inxight Drugs entry: Sermorelin
sibutramine sibutraminum; mono-desmethylsibutramine; N-1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl-N,N-dimethylamine HCl; sibutramine hydrochloride monohydrate; BTS-54524 (+8) DEA Controlled Substance List: Schedule IV FDA Drug Safety Communication Recommends Against Use
sildenafil Viagra Prescription drug NIH NCATS Inxight Drugs entry: Sildenafil
sodium tetrachloroaurate tetrachloroaurate (1-) sodium; gold chloride sodium; sodium tetrachloroaurate (1-); tetrachloroauric (3+) acid, sodium salt; sodium tetrachloroaurate (III) (+7) Unapproved Drug Finished Drug Product
solriamfetol benzenepropanol, beta-amino-, carbamate (ester); 2-amino-3-phenylpropyl carbamate; (2R)-2-amino-3-phenylpropyl carbamate; Sunosi DEA Controlled Substance List: Schedule IV; Prescription drug NIH NCATS Inxight Drugs entry: solriamfetol
somapacitan somapacitan-geco WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Somapacitan
somatorelin WADA S2: Peptide Hormones, Growth Factors, etc.; DoDI 1010.16 OPSS entry
somatrogon Ngenla; NGENLA WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
sotatercept ACE-011 WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
spironolactone CaroSpir; Aldactone; spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan); Verospiron WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Spironolactone
SR-18 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole; RCS-8 DEA Controlled Substance List: Schedule I OPSS entry
SR-19 RCS-4; 1-pentyl-3-[(4-methoxy)-benzoyl]indole; 1-pentyl-3-(4-methoxybenzoyl)indole DEA Controlled Substance List: Schedule I OPSS entry
SR-9009 ethyl 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]pyrrolidine-1-carboxylate; SR 9009; 1-pyrrolidinecarboxylic acid, 3-((((4-chlorophenyl)methyl)((5-nitro-2-thienyl)methyl)amino)methyl)-, ethyl ester; Stenabolic; SR9009 WADA S4: Hormone and Metabolic Modulators OPSS entry
SR-9011 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]-N-pentylpyrrolidine-1-carboxamide; SR9011; 1-pyrrolidinecarboxamide, 3-((((4-chlorophenyl)methyl)((5-nitro-2-thienyl)methyl)amino)methyl)-n-pentyl- WADA S4: Hormone and Metabolic Modulators OPSS entry
stanozolol 17β-hydroxy-17α-methylandrostano(3,2-c)pyrazole; 17alpha-methyl-17beta-hydroxy-5alphaandrost-2-eno[3,2-c]-pyrazole; 17α-methyl-17β-hydroxy-[5α]-androst-2-eno[3,2-c]-pyrazole; androstanazol; Winstrol (+4) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
stenbolone 17beta-hydroxy-2-methyl-5alpha-androst-1-en-3-one; 17β-hydroxy-2-methyl-[5α]-androst-1-en-3-one DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
sulbutiamine BRN 0741531; N,N'-(dithiobis(2-(2-hydroxyethyl)-1-methylvinylene))bis(N-((4-amino-2-methyl-5-pyrimidinyl)methyl)formamide) diisobutyrate (ester); Bisibutiamin; UNII-42NCM1BW43; O,O'-diisobutyrylthiamine disulfide (+8) FDA Warning Letter FDA Warning Letter
sulfondiethylmethane tetronal; 3,3-bis(ethylsulfonyl)pentane DEA Controlled Substance List: Schedule III OPSS entry
sulfonethylmethane DEA Controlled Substance List: Schedule III OPSS entry
sulfonmethane trional; methylsulfonal; 2,2-bis(ethylsulfonyl)butane DEA Controlled Substance List: Schedule III OPSS entry
sunifiram 1-benzoyl-4-propanoylpiperazine; piperazine, 1-benzoyl-4-(1-oxopropyl)-; DM-235; 1-benzyl-4-propanoylpiperazine; 1-propanone, 1-(4-benzoyl-1-piperazinyl)- Unapproved Drug NIH NCATS Inxight Drugs entry: Sunifiram
suvorexant [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone; MK-4305; Belsomra DEA Controlled Substance List: Schedule IV OPSS entry
synthetic cannabinoids pyrrolo-benzoxazine; cannabinoid derivative; indazole carboxamide cannabinoid; naphthoylindole cannabinoids; indole carboxylate cannabinoid (+3) DoDI 1010.16 OPSS entry
tabimorelin D-phenylalaninamide, N-((2E)-5-amino-5-methyl-1-oxo-2-hexen-1-YL)-N-methyl-3-(2-naphthalenyl)-D-alanyl-N,Nα-dimethyl-; D-phenylalaninamide, N-((2E)-5-amino-5-methyl-1-oxo-2-hexen-1-YL)-N-methyl-3-(2-naphthalenyl)-D-alanyl-N,Nalpha-dimethyl- WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
tadalafil Cialis Prescription drug NIH NCATS Inxight Drugs entry: Tadalafil
talbutal Lotusate DEA Controlled Substance List: Schedule III OPSS entry
tamoxifen Soltamox; ICI-47699; ICI46474; Novaldex; ICI47699 (+28) WADA S4: Hormone and Metabolic Modulators; Prescription drug NIH NCATS Inxight Drugs entry: Tamoxifen
tapentadol DEA Controlled Substance List: Schedule II OPSS entry
tauroursodeoxycholic acid TUDCA; ursodoxicoltaurine; tuaroursodeoxycholic acid; tauroursodeoxycholic acid (TUDCA) Discontinued drug NIH NCATS Inxight Drugs entry: ursodoxicoltaurine
TB-500 Ac-LKKTETQ WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
temazepam Restoril DEA Controlled Substance List: Schedule IV OPSS entry
terbutaline terbutaline sulfate WADA S3: Beta-2 Agonists; Prescription drug NIH NCATS Inxight Drugs entry: Terbutaline
tesamorelin egrifta WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Tesamorelin
tesofensine NS-2330 Unapproved Drug FDA Designated Orphan Drug
testolactone 1 dehydrotestolactone; 1-dehydrotestololactone; testolattone; EINECS 213-534-6; testolacton (+20) DEA Controlled Substance List: Schedule III; WADA S4: Hormone and Metabolic Modulators OPSS entry
testosterone testosterone undecanoate; testosterone propionate; Androlan; 17beta-hydroxyandrost-4-en-3-one; Andriol (+12) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
tetracosactide cosyntropin WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Cosyntropin
tetrahydrocannabinols delta-9-THC; 6 trans tetrahydrocannabinol; delta 8; HHC; 3, 4 trans tetrahydrocannabinol (+16) DEA Controlled Substance List: Schedule I OPSS entry
tetrahydrofuranyl fentanyl N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide DEA Controlled Substance List: Schedule I OPSS entry
tetrahydrogestrinone 13β,17α-diethyl-17β-hydroxygon-4,9,11-trien-3-one; 13beta,17alpha-diethyl-17betahydroxygon-4,9,11-trien-3-one; 17-hydroxy-18a-homo-19-nor-17α-pregna-4,9,11-trien-3-one; 17β-Hydroxy-18α-homo-19-nor-17α-pregna-4,9,11-trien-3- one; THG DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
tetrazepam Myolastan; Musaril DEA Controlled Substance List: Schedule IV OPSS entry
thebacon acetylhydrocodone; Acedicon; Thebacetyl DEA Controlled Substance List: Schedule I OPSS entry
thebaine paramorphine; codeine methyl enol ether; 3-O-methyl-oripavin DEA Controlled Substance List: Schedule II OPSS entry
thiafentanil Thianil DEA Controlled Substance List: Schedule II OPSS entry
thiamylal Surital DEA Controlled Substance List: Schedule III OPSS entry
thiazolidene tetrahydrothiazole; 1,3-thiazolidine; 1-thia-3-azacyclopentane DoDI 1010.16 OPSS entry
thiofentanyl N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide DEA Controlled Substance List: Schedule I OPSS entry
thiofuranyl fentanyl N-(1-phenethylpiperidin-4-yl)-Nphenylthiophene-2-carboxamide; 2-thiofuranyl fentanyl; thiophene fentanyl DEA Controlled Substance List: Schedule I OPSS entry
thiomesterone Emdabol; 1,7-bis(acetylthio)-17β-hydroxy-17α-methyl-androst-4-en-3- one WADA S1: Anabolic Agents; DoDI 1010.16 OPSS entry
thiopental Pentothal DEA Controlled Substance List: Schedule III OPSS entry
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone DEA Controlled Substance List: Schedule I OPSS entry
thymosin beta 4 thymosin-β4; Timbetasin; Tβ4 WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
tianeptine Coaxil; tianeptine acid; 7-[(3-chloro-6-methyl-5,5-dioxo-11H-benzo[c][2,1]benzothiazepin-11-yl)amino] heptanoic acid; tianeptine sulfate; Tianaa (+6) FDA Statement FDA: Tianeptine
tibolone 17-hydroxy-7α-methyl-19-nor-17α-pregn-5(10)-en-20-yn-3-one; 17-hydroxy-7alpha-methyl-19-nor-17alpha-pregn-5(10)-en-20-yn-3-one WADA S1: Anabolic Agents OPSS entry
tiletamine Telazol; 2-(ethylamino)-2-(2-thienyl)-cyclohexanone DEA Controlled Substance List: Schedule III OPSS entry
tilidine Lak; Kitadol; Tilsa; Tilidate; Valoron DEA Controlled Substance List: Schedule I OPSS entry
tirasemtiv CK-2017357 WADA S0: Non-approved Substances OPSS entry
TMA 3,4,5-trimethoxyamphetamine; 3,4,5-trimethoxy amphetamine; 2,4,5-trimethoxyamphetamine; TMA-6; escaline (+2) DEA Controlled Substance List: Schedule I OPSS entry
tolvaptan Jynarque WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Tolvaptan
torasemide torsemide; Demadex WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Torsemide
toremifene Fareston; GTx 006; toremifeno; NK 622; toremifene citrate (+9) WADA S4: Hormone and Metabolic Modulators; Prescription drug NIH NCATS Inxight Drugs entry: Toremifene
tramadol 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol; tramadol hydrochloride DEA Controlled Substance List: Schedule IV OPSS entry
trenbolone trenbolone enanthate; 17beta-trenbolone; Finaplix-S; Parabolan; 17 beta-acetoxyestr-4,9,11-trien-3-one (+8) DEA Controlled Substance List: Schedule III; WADA S1: Anabolic Agents OPSS entry
trestolone MENT; trestolone phenylpropionate; 19-nor-methyltestosterone; 7α-methyl-19-nortestosterone; trestolone acetate [7a-methyl-17ß-hydroxyestr-4-en-3-one acetate] (+5) WADA S1: Anabolic Agents OPSS entry
tretoquinol tretoquinol, (+)-; trimethoquinol; trimetoquinol WADA S3: Beta-2 Agonists OPSS entry
triacetyluridine uridine triacetate; TAU; Xuriden Prescription drug NIH NCATS Inxight Drugs entry: Uridine triacetate
triamterene 6-phenylpteridine-2,4,7-triamine; 2,4,7-triamino-6-phenylpteridine; Dyrenium WADA S5: Diuretics and Masking Agents; Prescription drug NIH NCATS Inxight Drugs entry: Triamterene
triazolam Halcion DEA Controlled Substance List: Schedule IV OPSS entry
trimeperidine Promedolum DEA Controlled Substance List: Schedule I OPSS entry
trimetazidine Centrophène; 1-(2,3,4-trimethoxybenzyl)piperazine; dihydrochloride, trimetazidine; Idaptan; trimetazidinum (+10) WADA S4: Hormone and Metabolic Modulators OPSS entry
triptorelin Triptodur; Arvekap WADA S2: Peptide Hormones, Growth Factors, etc.; Prescription drug NIH NCATS Inxight Drugs entry: Triptorelin
tulobuterol alpha-((tert-butylamino)methyl)-O-chlorobenzyl alcohol; α-((tert-butylamino)methyl)-O-chlorobenzyl alcohol WADA S3: Beta-2 Agonists OPSS entry
U-47700 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide DEA Controlled Substance List: Schedule I OPSS entry
unifiram DM-232; pyrrolo(1,2-A)pyrazin-6(2H)-one, 2-((4-fluorophenyl)sulfonyl)hexahydro-; 2-((4-fluorophenyl)sulfonyl)hexahydropyrrolo(1,2-A)pyrazin-6(2H)-one Unapproved Drug NIH NCATS Inxight Drugs entry: Unifiram
UR-144 (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone DEA Controlled Substance List: Schedule I OPSS entry
vadadustat AKB-6548 WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
valeryl fentanyl N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide DEA Controlled Substance List: Schedule I OPSS entry
vilanterol GW-642444X; GW-642444; GW642444 WADA S3: Beta-2 Agonists; Prescription drug NIH NCATS Inxight Drugs entry: Vilanterol
vinbarbital Delvinal; vinbarbitone DEA Controlled Substance List: Schedule III OPSS entry
vinpocetine 3-α,16-α-apovincaminic acid ethyl ester; ethyl apovincamin-22-oate; Cavinton; Ceractin; ethyl (3α,16α)-eburnamenine-14-carboxylate (+6) FDA Statement FDA: Vinpocetine in Dietary Supplements
vosilasarm RAD-140 testolone; Testolone; 2-chloro-4-[[(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile; RAD140; 2-chloro-4-((1R,2S)-1-(5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl)-2-hydroxypropylamino)-3-methylbenzonitrile (+3) WADA S1: Anabolic Agents; FDA Statement Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
xanthinol 7-[2-hydroxy-3-[2-hydroxyethyl-methyl-amino)propyl]-1,3dimethylpurine-2,6-dione; xanthinol nicotinate; xantinol; Jupal Unapproved Drug NIH NCATS Inxight Drugs entry: xanthinol
xenon WADA S2: Peptide Hormones, Growth Factors, etc. OPSS entry
xipamide WADA S5: Diuretics and Masking Agents OPSS entry
YK-11 YK-500; 19-norpregna-4,20-diene-21-carboxylic acid, 17,20-((1-methoxyethylidene)bis(oxy))-3-oxo-, methyl ester, (17alpha,20E)-; methyl(2E)-2-[(8R,9S,10R,13S,14S,17R)-2’-methoxy-2’,13-dimethyl-3-0x0spiro[1,2,6.7,8,9,10,11,12,14,15,16-dodecahydroyclopenta[; (17-α,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3- oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester); YK 11 (+6) WADA S1: Anabolic Agents; FDA Statement Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
zaleplon Sonata DEA Controlled Substance List: Schedule IV OPSS entry
zeranol (3S,7R)-7,14,16-trihydroxy-3-methyl-3,4,5,6,7,8,9,10,11,12-decahydro-1H-2-benzoxacyclotetradecin-1-one WADA S1: Anabolic Agents OPSS entry
zilpaterol imidazo(4,5,1-jk)(1)benzazepin-2(1H)-one, 4,5,6,7-tetrahydro-7-hydroxy-6-((1-methylethyl)amino)-, trans-(+-)-; imidazo(4,5,1-jk)(1)benzazepin-2(1H)-one, 4,5,6,7-tetrahydro-7-hydroxy-6-((1-methylethyl)amino)-, (6R,7R)-rel- WADA S1: Anabolic Agents OPSS entry
zipeprol 1-methoxy-3[-4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol DEA Controlled Substance List: Schedule I OPSS entry
zolazepam 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one; flupyrazapon DEA Controlled Substance List: Schedule III OPSS entry
zolpidem Ambien; Stilnoct; Ivadal; N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamid; Stilnox DEA Controlled Substance List: Schedule IV OPSS entry
zopiclone Lunesta; Imovane; Zimovane DEA Controlled Substance List: Schedule IV OPSS entry
zuranolone Zurzuvae DEA Controlled Substance List: Schedule IV OPSS entry

Names, synonyms, reasons and references are OPSS’s own text for each entry, retrieved through the site’s search API on 2026-09-21; where an entry carries no reference link, the link goes to the OPSS search page.

How a banned ingredient reaches a bottle

A dietary supplement needs no approval before sale, and its maker, not FDA, is responsible for what goes in it. FDA finds a hidden drug after the fact, in four ways that show up as the “action” column above: import screening at the border (the “International Mail Shipments” rows), laboratory testing of products bought online, consumer and physician adverse-event reports through MedWatch, and inspections that end in a warning letter. The result is a public notification, sometimes a voluntary recall by the firm, and the product joins the database. FDA’s own caveat, printed on the database page, is that the list is a small fraction of what is sold.

The three product types that dominate the notifications share one mechanism. A “natural” sexual-enhancement capsule that works reliably usually works because it contains sildenafil or tadalafil, or an analogue nobody has tested in humans; a weight-loss tea that works usually contains sibutramine, an appetite suppressant withdrawn from the US market for cardiovascular risk, or phenolphthalein, a former laxative ingredient no longer approved for sale in the US; a muscle-building product that works usually contains an anabolic steroid or a SARM. The ingredient list on the label is the marketing; the drug is the product. Contamination with heavy metals or microbes is a manufacturing failure; a hidden drug is a design choice.

The ingredient directory captures a second route: substances sold openly as supplement ingredients that FDA says are not dietary ingredients at all. DMAA, for example, is category 3 in the directory (entry 2023/03), phenibut is category 3 (2023/03), tianeptine is category 2/3 (2023/03), and kratom is category 2/6 (2023/03); the category key is under the table above. These are not hidden; they are printed on the label of products still on sale, which is why the DoD keeps its own list for a population that is drug-tested.

How to check a product

  1. Search the product name in the FDA tainted-products table above (the full 1,406-row set is in the JSON file) and in FDA’s live database, which updates after this page’s fetch date.
  2. Read the ingredient panel against the ingredient directory and, if you are a service member, the DoD list. Search synonyms: the directory and OPSS both list them because labels use them.
  3. Check whether anyone tested the bottle. Our third-party tested database places every product we track on three tiers; a sport certification (NSF Certified for Sport, Informed Sport) is the only tier that screens each lot for banned substances, which is why the DoD and most leagues name those marks.
  4. Check the recall feed. Our supplement recalls page tracks FDA enforcement reports, including recalls for undeclared drug ingredients.
  5. Distrust the shape. A product promising sexual performance, rapid weight loss or muscle gain, sold through marketplaces or international mail, is the shape of 1,323 of the 1,406 notifications above.

Frequently asked questions

Is there an official FDA banned supplements list?

No. FDA does not maintain a single list of banned dietary supplements. What exists is (1) the FDA Health Fraud Product Database, which as of 2026-09-21 holds 1,406 product notifications naming a hidden or undeclared drug ingredient in a product sold as a supplement, from 2007 to 2026; (2) FDA's Dietary Supplement Ingredient Directory, 84 ingredients with FDA's statements, of which 61 are marked as not lawful dietary ingredients; and (3) for service members only, the Department of Defense prohibited-ingredients database maintained by Operation Supplement Safety (850 entries reachable through its search on 2026-09-21).

What supplements are banned by the military?

The Department of Defense prohibits service members from using any substance in its Operation Supplement Safety database as a dietary supplement ingredient, under DoD Instruction 6130.06, plus all controlled substances and drugs. The database is a search box with no download; we reached 850 ingredient entries through 3,000 queries on 2026-09-21, and because the crawl hit its budget before the queue emptied, that count is a lower bound. The list was last updated by OPSS on 26 May 2026. The most common reasons attached to entries are DEA Controlled Substance List: Schedule I (283), DEA Controlled Substance List: Schedule III (110), WADA S1: Anabolic Agents (110), DEA Controlled Substance List: Schedule IV (80), DEA Controlled Substance List: Schedule II (62), Prescription drug (62).

Is DMAA banned in supplements?

FDA's ingredient directory lists DMAA (1,3-DMAA; 1,3-Dimethylamylamine; 1,3-Dimethylpentylamine; 4-Methyl-2-hexanamine) under category 3: Ingredient is not a "dietary ingredient" under section 201(ff)(1) of the FD&C Act. FDA's position is that DMAA is not a lawful dietary ingredient and products containing it are adulterated; the directory entry links FDA's statement and enforcement actions (entry dated 2023/03). It is also on the DoD prohibited list.

What is the most common hidden ingredient in tainted supplements?

In the 1,406 hidden-ingredient notifications in the FDA database, the most frequent named ingredient is sildenafil (458 rows), followed by sibutramine (350) and tadalafil (261). By product type, 802 notifications involve sexual-enhancement drugs (sildenafil, tadalafil and their analogues), 428 involve weight-loss drugs (sibutramine, phenolphthalein, fluoxetine) and 93 involve anabolic steroids or SARMs; the category is our classification of the hidden ingredient, not an FDA field.

How do I report a supplement that made me sick?

Use FDA's MedWatch program (fda.gov/medwatch) for a product sold in the United States; keep the container and lot number. Service members and their providers can also report through the OPSS site. Reports feed the adverse-event data we summarise on our safety page and are how many of the notifications in the tables above started.

Related

Sources

  1. US FDA. Health Fraud Product Database. https://www.fda.gov/consumers/health-fraud-scams/health-fraud-product-database (fetched 2026-09-21; 2,202 rows, 1,406 with a hidden-ingredient subject). Former address: Tainted Products Marketed as Dietary Supplements.
  2. US FDA. Information on Select Dietary Supplement Ingredients and Other Substances (Dietary Supplement Ingredient Directory). https://www.fda.gov/food/dietary-supplements/information-select-dietary-supplement-ingredients-and-other-substances (content current as of 2026-05-01; fetched 2026-09-21; 84 entries).
  3. Operation Supplement Safety, Uniformed Services University. DoD Prohibited Dietary Supplement Ingredients. https://www.opss.org/dod-prohibited-dietary-supplement-ingredients (fetched 2026-09-21; 850 entries via 3,000 search queries; list dated 26 May 2026).
  4. Department of Defense. DoD Instruction 6130.06, Use of Dietary Supplements in the DoD. opss.org
  5. US FDA. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. fda.gov/medwatch
  6. Verified Supplement Data. banned-supplements.json, the open-data version of the three lists (CC BY 4.0).